,Date,Title,Url
0,2019-01-04,SK바이오팜솔리암페톨유럽허가심사돌입美허가에쏠리는눈,http://www.ceoscoredaily.com/news/article.html?no=50582
1,2019-01-14,글로벌무대밝히는K바이오SK바이오팜AI약물설계플랫폼개발신약개발비용기간단축,http://www.sedaily.com/NewsView/1VE194FQK1
2,2019-01-16,더벨SK바이오팜글로벌신약2개로미국시장본격공략,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201901140100023560001457
3,2019-01-17,SK바이오팜솔리암페톨올美이어유럽서도허가유력,http://www.medisobizanews.com/news/articleView.html?idxno=57429
4,2019-01-17,SKSK바이오팜IPO로재평가기대미래에셋대우,http://www.ebn.co.kr/news/view/969096
5,2019-01-17,SKSK바이오팜기업공개에따른재평가예상,http://www.newsworks.co.kr/news/articleView.html?idxno=328590
6,2019-01-17,SK주식은지금이매입적기자회사SK바이오팜사업가치커져,http://www.businesspost.co.kr/BP?command=article_view&num=110701
7,2019-01-29,2019K바이오이끌기업삼성바이오시밀러글로벌1위우뚝한미약품SK바이오팜신약개발박차,http://news.mk.co.kr/v2/economy/view.php?year=2019&no=59439
8,2019-02-07,SK바이오팜세노바메이트미FDA신약허가심사착수,http://www.asiatoday.co.kr/view.php?key=20190207010001301
9,2019-02-07,SK바이오팜FDA세노바메이트신약허가심사착수,http://medipana.com/news/news_viewer.asp?NewsNum=234324&MainKind=A&NewsKind=5&vCount=12&vKind=1
10,2019-02-07,SK바이오팜세노바메이트美FDA허가심사착수,http://www.ebn.co.kr/news/view/971694
11,2019-02-07,SK바이오팜뇌전증신약미국FDA허가심사개시,http://yna.kr/AKR20190207045200017?did=1195m
12,2019-02-07,SK바이오팜세노바메이트美신약허가심사,http://www.medical-tribune.co.kr/news/articleView.html?idxno=83876
13,2019-02-07,SK바이오팜뇌전증신약미국FDA허가심사개시,http://www.sentv.co.kr/news/view/548546
14,2019-02-07,SK바이오팜세노바메이트미국FDA신약허가심사착수,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226968
15,2019-02-07,SK바이오팜세노바메이트美FDA신약허가심사개시,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019020709390796187
16,2019-02-07,SK바이오팜뇌전증치료제세노바메이트美신약허가심사착수,http://biz.newdaily.co.kr/site/data/html/2019/02/07/2019020700025.html
17,2019-02-07,SK바이오팜뇌전증신약세노바메이트FDA심사착수,http://www.edaily.co.kr/news/newspath.asp?newsid=02240246622388224
18,2019-02-07,SK바이오팜뇌전증신약세노바메이트美FDA허가심사착수,http://www.mdtoday.co.kr/mdtoday/index.html?no=345742
19,2019-02-07,SK바이오팜FDA세노바메이트허가심사개시11월21일결론,http://news.mk.co.kr/newsRead.php?year=2019&no=74965
20,2019-02-07,SK바이오팜미FDA뇌전증신약허가심사착수,http://www.dailypharm.com/Users/News/NewsView.html?ID=249242&REFERER=NP
21,2019-02-07,SK바이오팜뇌전증치료제미국허가심사시작11월21일결론,http://www.newspim.com/news/view/20190207000262
22,2019-02-07,SK바이오팜세노바메이트美FDA신약허가심사착수,http://www.bosa.co.kr/news/articleView.html?idxno=2099075
23,2019-02-07,SK바이오팜뇌전증신약세노바메이트美FDA허가심사착수,http://www.etoday.co.kr/news/section/newsview.php?idxno=1719082
24,2019-02-07,SK바이오팜美FDA뇌전증신약허가심사착수,http://view.asiae.co.kr/news/view.htm?idxno=2019020710431562258
25,2019-02-07,SK바이오팜세노바메이트美FDA신약허가심사착수,http://news.mk.co.kr/newsRead.php?year=2019&no=75164
26,2019-02-07,美FDASK바이오팜뇌전증신약세노바메이트허가심사착수,http://news1.kr/articles/?3541976
27,2019-02-07,SK바이오팜미FDA서세노바메이트허가심사착수,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902070275&t=NN
28,2019-02-07,SK바이오팜뇌전증신약세노바메이트FDA신약허가심사착수,http://www.econovill.com/news/articleView.html?idxno=356105
29,2019-02-07,SK바이오팜세노바메이트美FDA신약허가심사착수,http://www.metroseoul.co.kr/news/newsview?newscd=2019020700087
30,2019-02-07,SK바이오팜뇌전증신약美FDA판매허가심사받는다,http://www.dt.co.kr/contents.html?article_no=2019020702109931102002&ref=naver
31,2019-02-07,美FDASK바이오팜뇌전증신약세노바메이트허가심사진행,http://www.fntoday.co.kr/news/articleView.html?idxno=179897
32,2019-02-07,SK바이오팜뇌전증신약FDA심사착수,http://www.whosaeng.com/107826
33,2019-02-07,SK바이오팜뇌전증신약FDA허가심사착수,http://news.mt.co.kr/mtview.php?no=2019020710183091731
34,2019-02-07,SK바이오팜세노바메이트미FDA신약허가심사착수,http://www.fnnews.com/news/201902071450584827
35,2019-02-07,SK바이오팜뇌전증신약후보물질세노바메이트FDA허가심사착수,http://www.newstomato.com/ReadNews.aspx?no=874420
36,2019-02-07,SK바이오팜개발뇌전증신약미국FDA허가심사개시 ,http://www.seoulfn.com/news/articleView.html?idxno=332995
37,2019-02-07,조정우SK바이오팜뇌전증신약의미국공략계획순항,http://www.businesspost.co.kr/BP?command=article_view&num=113145
38,2019-02-07,SK바이오팜세노바메이트美FDA신약허가심사착수,http://www.newsway.co.kr/news/view?tp=1&ud=2019020717001648307
39,2019-02-07,뇌전증신약물질세노바메이트SK바이오팜FDA심사착수,http://www.sedaily.com/NewsView/1VF7ZMVPN5
40,2019-02-07,SK바이오팜뇌전증신약미국FDA11월허가예상,http://www.etnews.com/20190207000283
41,2019-02-07,SK바이오팜세노바메이트미국신약허가심사착수,http://www.kpanews.co.kr/article/show.asp?idx=201349&table=article&category=D
42,2019-02-08,USFDAtoreviewSKBiopharmasCenobamateforepilepsytreatmentSK바이오팜세노바메이트美FDA신약허가심사착수,http://premium.mk.co.kr/view.php?no=24758
43,2019-02-08,SK바이오팜뇌전증신약세노바메이트美허가신청,http://www.ajunews.com/view/20190208113306901
44,2019-02-10,SK바이오팜뇌전증신약세노바메이트美FDA신약심사착수,http://www.kukinews.com/news/article.html?no=630235
45,2019-02-13,SK바이오팜26년신약개발사업결실보나,http://www.edaily.co.kr/news/newspath.asp?newsid=01285766622390192
46,2019-02-14,SK바이오팜스위스아벨과뇌전증신약후보물질세노바메이트6000억규모기술수출,http://www.fnnews.com/news/201902141534272711
47,2019-02-14,SK바이오팜뇌전증신약유럽32개국에5억달러규모기술수출성공,http://www.mdtoday.co.kr/mdtoday/index.html?no=346440
48,2019-02-14,SK바이오팜뇌전증신약유럽에5억달러기술수출,http://www.ebn.co.kr/news/view/972688
49,2019-02-14,SK바이오팜뇌전증신약유럽32개국에6천억원규모기술수출,http://www.ceoscoredaily.com/news/article.html?no=52045
50,2019-02-14,SK바이오팜스위스아벨사와뇌전증신약6천억기술수출,http://medipana.com/news/news_viewer.asp?NewsNum=234621&MainKind=A&NewsKind=5&vCount=12&vKind=1
51,2019-02-14,SK바이오팜뇌전증신약후보물질6000억규모기술수출,http://news.mt.co.kr/mtview.php?no=2019021416260588790
52,2019-02-14,SK바이오팜뇌전증신약5억달러규모기술수출성공,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019021417072596964
53,2019-02-14,SK바이오팜뇌전증신약유럽32개국6000억규모기술수출,http://biz.chosun.com/site/data/html_dir/2019/02/14/2019021402417.html
54,2019-02-14,SK바이오팜뇌전증신약기술수출총6천억규모,http://www.dailypharm.com/Users/News/NewsView.html?ID=249466&REFERER=NP
55,2019-02-14,5억弗기술수출유럽서빛난SK바이오팜뚝심,https://www.sedaily.com/NewsView/1VFB7QNX3V
56,2019-02-14,SK바이오팜뇌전증치료제세노바메이트유럽32개국6000억규모기술수출,http://biz.newdaily.co.kr/site/data/html/2019/02/14/2019021400220.html
57,2019-02-14,SK바이오팜뇌전증신약6000억규모유럽진출신호탄,http://moneys.mt.co.kr/news/mwView.php?no=2019021417058079602
58,2019-02-14,SK바이오팜뇌전증신약유럽32개국에6000억기술수출,http://www.newsis.com/view/?id=NISX20190214_0000558901&cID=13001&pID=13000
59,2019-02-14,SK바이오팜뇌전증신약유럽에6000억규모기술수출,http://www.etnews.com/20190214000472
60,2019-02-14,SK바이오팜뇌전증파이프라인의유럽권리기술수출53억달러규모,http://news.mk.co.kr/newsRead.php?year=2019&no=92260
61,2019-02-14,SK바이오팜뇌전증혁신신약유럽에5억달러기술수출,http://www.techholic.co.kr/news/articleView.html?idxno=180636
62,2019-02-14,SK바이오팜뇌전증신약유럽32개국6000억기술수출,http://www.newsway.co.kr/news/view?tp=1&ud=2019021417451706786
63,2019-02-14,SK바이오팜유럽에뇌전증신약기술수출6000억규모,http://www.newsworks.co.kr/news/articleView.html?idxno=336300
64,2019-02-14,SK바이오팜뇌전증신약유럽에5억달러규모기술수출,http://view.asiae.co.kr/news/view.htm?idxno=2019021418000083887
65,2019-02-14,SK바이오팜뇌전증신약후보물질기술수출,http://www.fnnews.com/news/201902141812573536
66,2019-02-14,SK바이오팜유럽에5억달러규모뇌전증신약기술수출,http://www.businesspost.co.kr/BP?command=article_view&num=114293
67,2019-02-14,SK바이오팜독자개발뇌전증신약기술스위스기업아벨에5억달러수출계약,http://news.kmib.co.kr/article/view.asp?arcid=0924062034&code=11151400&cp=nv
68,2019-02-14,SK바이오팜뇌전증치료제유럽에6천억원기술수출,http://www.medical-tribune.co.kr/news/articleView.html?idxno=84028
69,2019-02-14,SK바이오팜스위스신생회사에5억3000만달러규모기술이전,http://www.nspna.com/news/?mode=view&newsid=338797
70,2019-02-15,SK바이오팜뇌전증신약스위스에6000억원수출,http://biz.chosun.com/site/data/html_dir/2019/02/15/2019021500088.html?utm_source=naver&utm_medium=original&utm_campaign=biz
71,2019-02-15,개발완료신약의매력SK바이오팜계약금역대3위,http://www.dailypharm.com/Users/News/NewsView.html?ID=249479&REFERER=NP
72,2019-02-15,HotLineSK바이오팜기술수출계기로신약가치재조명될것,http://news.mk.co.kr/newsRead.php?year=2019&no=92974
73,2019-02-15,SK바이오팜스위스아벨에뇌전증신약6천억원규모기술수출,http://www.medisobizanews.com/news/articleView.html?idxno=57910
74,2019-02-15,SK주가오를기반다져자회사SK바이오팜신약기술수출,http://www.businesspost.co.kr/BP?command=article_view&num=114311
75,2019-02-15,SK바이오팜의뇌전증신약유럽수출로신약가치입증대신,http://www.edaily.co.kr/news/newspath.asp?newsid=01981126622390848
76,2019-02-15,SK바이오팜지분가치상향SK주가재평가예상”미래에셋대우,http://www.fntimes.com/html/view.php?ud=201902150902135387f09e13944d_18
77,2019-02-15,특징주SK바이오팜유럽수출허가소식에상승,http://www.edaily.co.kr/news/newspath.asp?newsid=02273046622390848
78,2019-02-15,SK바이오팜뇌전증신약유럽32개국6000억수출,http://www.upinews.kr/news/newsview.php?ncode=1065571582356697
79,2019-02-15,특징주SKSK바이오팜기술수출계약체결소식에강세,http://www.seoulfn.com/news/articleView.html?idxno=333737
80,2019-02-15,26년신약개발열매따는SK바이오팜미국유럽동시진출,http://biz.newdaily.co.kr/site/data/html/2019/02/15/2019021500039.html
81,2019-02-15,SK바이오팜스위스에독자개발뇌전증신약수출,https://cnbc.sbs.co.kr/article_hub/10000931101?division=NAVER
82,2019-02-15,ET투자뉴스SKSK바이오팜뇌전증BUY대신증권,http://www.etnews.com/20190215000146
83,2019-02-15,SK자회사SK바이오팜이뇌전증신약세노바메이트유럽판권수출,http://www.newsworks.co.kr/news/articleView.html?idxno=336522
84,2019-02-15,SK바이오팜뇌전증신약6000억규모기술수출,http://www.kpinews.co.kr/news/articleView.html?idxno=90440
85,2019-02-15,ET투자뉴스SKSK바이오팜가치매수미래에셋대우,http://www.etnews.com/20190215000284
86,2019-02-15,SK바이오팜스위스아벨에뇌전증신약세노바메이트기술수출,http://www.nextdaily.co.kr/news/article.html?id=20190215800029
87,2019-02-17,SK바이오팜뇌전증신약美진입한보앞으로,http://www.mdtoday.co.kr/mdtoday/index.html?no=346289
88,2019-02-17,SK바이오팜기술수출제약바이오에온기줄까,http://view.asiae.co.kr/news/view.htm?idxno=2019021516162908488
89,2019-02-17,SK바이오팜뇌전증신약6000억기술수출쾌거,http://www.dailymedi.com/detail.php?number=840089&thread=22r05
90,2019-02-18,SK신약개발가시화로SK바이오팜기업가치↑배당확대기대하이,http://www.edaily.co.kr/news/newspath.asp?newsid=01394006622391832
91,2019-02-18,SK주가오른다자회사SK바이오팜기업가치10배상승가능,http://www.businesspost.co.kr/BP?command=article_view&num=114562
92,2019-02-18,SKSK바이오팜기업가치증가로배당확대전망매수하이투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1723203
93,2019-02-18,SKSK바이오팜기업가치상향에올해배당확대가능성↑하이투자證,http://www.seoulfn.com/news/articleView.html?idxno=333885
94,2019-02-18,조정우SK바이오팜대표뇌전증신약기술수출신약개발결실맺나,http://www.ekn.kr/news/article.html?no=415316
95,2019-02-18,SK신약개발가시화로SK바이오팜기업가치레벨업될듯,http://www.newsworks.co.kr/news/articleView.html?idxno=337177
96,2019-02-19,글로벌Biz24SK바이오팜이기술수출한스위스아벨테라퓨틱스시리즈A파이낸싱에서1억8000만달러자금조달에성공,http://www.g-enews.com/ko-kr/news/article/news_all/2019021917171947194b5829de2_1/article.html
97,2019-02-22,SK바이오팜한미신약으로美장벽넘는다,http://www.newsway.co.kr/news/view?tp=1&ud=2019022214463992382
98,2019-02-23,신약개발돋보기SK바이오팜자체개발로선진국뚫는뇌전증약세노바메이트,http://www.edaily.co.kr/news/newspath.asp?newsid=01210326622393472
99,2019-02-25,SK자회사SK바이오팜의신약출시가시화로기업가치높아져,http://www.businesspost.co.kr/BP?command=article_view&num=115691
100,2019-02-26,더벨SK바이오팜뇌전증신약일본진출잰걸음,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201902250100038580002453
101,2019-02-27,재즈연내SK바이오팜수면장애신약미국출시,http://www.dailypharm.com/Users/News/NewsView.html?ID=249899&REFERER=NP
102,2019-03-01,하이투자증권SK신약개발가시화로SK바이오팜기업가치상승기대목표가36만8000원,http://www.betanews.net:8080/article/981157.html
103,2019-03-06,SKSK바이오팜신약개발로기업가치재고”하이투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1730075
104,2019-03-06,SK바이오팜기업가치향상기대SK배당확대예상”하이투자증권,http://www.fntimes.com/html/view.php?ud=201903060858126617f09e13944d_18
105,2019-03-06,SK신약개발가시화로SK바이오팜기업가치레벨업될듯,http://www.newsworks.co.kr/news/articleView.html?idxno=341320
106,2019-03-13,SKSK바이오팜상장추진에주목하나금융투자,http://www.ajunews.com/view/20190313000144473
107,2019-03-13,SK바이오팜재평가주주환원여력에주목하나금융투자,http://news.mt.co.kr/mtview.php?no=2019031308073125109
108,2019-03-13,I리포트SKSK바이오팜재평가–하나금투,http://www.inews24.com/view/1163369
109,2019-03-13,하나금투SKSK바이오팜美FDA승인상장수혜에투자의견매수,http://www.enewstoday.co.kr/news/articleView.html?idxno=1280019
110,2019-03-13,SK자회사SK바이오팜FDA승인및상장추진예상,http://www.nspna.com/news/?mode=view&newsid=344855
111,2019-03-13,SKSK바이오팜재평가고배당주매력하나금투,http://www.ekn.kr/news/article.html?no=419998
112,2019-03-13,SK자회사SK바이오팜재평가가모멘텀하나금융투자,https://www.sedaily.com/NewsView/1VGKN686VZ
113,2019-03-13,SK주가오를힘갖춰자회사SK바이오팜상장하면기업가치커져,http://www.businesspost.co.kr/BP?command=article_view&num=118117
114,2019-03-13,하나금투SK바이오팜FDA승인및상장추진예상,http://www.seoulwire.com/news/articleView.html?idxno=86596
115,2019-03-13,하나금투SK자회사SK바이오팜美FDA승인및상장에수혜”,http://www.kukinews.com/news/article.html?no=640694
116,2019-03-13,SK바이오팜신약FDA허가상장올해핵심모멘텀,http://medipana.com/news/news_viewer.asp?NewsNum=235862&MainKind=A&NewsKind=5&vCount=12&vKind=1
117,2019-03-13,SKSK바이오팜파이프라인美FDA승인및상장추진예정”,http://www.wikitree.co.kr/main/news_view.php?id=411033
118,2019-03-14,SK주가올라SK바이오팜성장덕에기업가치높아져,http://www.businesspost.co.kr/BP?command=article_view&num=118479
119,2019-03-15,ET투자뉴스SKSK바이오팜재평가BUY하나금융투자,http://www.etnews.com/20190315000088
120,2019-03-21,클릭e종목SK바이오팜SK기업가치개선의핵심요인”,http://view.asiae.co.kr/news/view.htm?idxno=2019032107365308200
121,2019-03-21,한투證SK바이오팜SK기업가치핵심요인될것,http://www.newsis.com/view/?id=NISX20190321_0000594169&cID=10401&pID=10400
122,2019-03-21,SK바이오팜기면증치료제美FDA허가26년만에결실상보,http://www.edaily.co.kr/news/newspath.asp?newsid=01462886622425616
123,2019-03-21,단독SK바이오팜기면증치료제美신약허가획득,http://www.edaily.co.kr/news/newspath.asp?newsid=01459606622425616
124,2019-03-21,한투證SK바이오팜SK기업가치개선의핵심요인될것”,http://www.newsway.co.kr/news/view?tp=1&ud=2019032108231484240
125,2019-03-21,더벨SK바이오팜1호신약미국뚫었다,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201903210100036900002344
126,2019-03-21,미FDASK바이오팜수출수면장애신약최종허가,http://www.dailypharm.com/Users/News/NewsView.html?ID=250662&REFERER=NP
127,2019-03-21,SKSK바이오팜기술수출신약FDA판매승인,http://yna.kr/AKR20190321032200008?did=1195m
128,2019-03-21,SK바이오팜수면장애신약미국식품의약국판매승인,http://www.etoday.co.kr/news/section/newsview.php?idxno=1736136
129,2019-03-21,한투證SK바이오팜SK기업가치개선핵심요인될것”,http://www.kukinews.com/news/article.html?no=643609
130,2019-03-21,SK바이오팜수면장애신약美FDA판매승인,http://news.mt.co.kr/mtview.php?no=2019032108532284582
131,2019-03-21,SK바이오팜수면장애신약FDA승인,https://www.sedaily.com/NewsView/1VGOCCFMIB
132,2019-03-21,SK자회사SK바이오팜점유율확대기업가치개선전망한국,https://www.sedaily.com/NewsView/1VGOBK4HBC
133,2019-03-21,SK바이오팜수면장애치료신약美FDA판매승인,http://www.ebn.co.kr/news/view/977382
134,2019-03-21,SK바이오팜기술수출수면장애치료신약美FDA승인,http://www.asiatoday.co.kr/view.php?key=20190321010012548
135,2019-03-21,SKSK바이오팜기술수출신약FDA판매승인,http://www.newspim.com/news/view/20190321000148
136,2019-03-21,공시SKSK바이오팜기술수출신약FDA판매승인”,http://www.newsway.co.kr/news/view?tp=1&ud=2019032109084747895
137,2019-03-21,SK바이오팜개발기면증치료제3조시장본격출격종합,http://www.edaily.co.kr/news/newspath.asp?newsid=01787606622425616
138,2019-03-21,SK바이오팜시장영향력확대전망,http://www.nspna.com/news/?mode=view&newsid=346889
139,2019-03-21,SK바이오팜수면신약솔리암페톨美허가획득성공,http://www.ceoscoredaily.com/news/article.html?no=53297
140,2019-03-21,최태원의뚝심美뚫었다SK바이오팜1호신약FDA허가종합,http://www.newsway.co.kr/news/view?tp=1&ud=2019032109242246055
141,2019-03-21,SK바이오팜수면장애신약솔리암페톨미FDA승인,http://www.fnnews.com/news/201903210926429060
142,2019-03-21,SK바이오팜수면장애신약솔리암페톨미국FDA허가,http://medipana.com/news/news_viewer.asp?NewsNum=236258&MainKind=A&NewsKind=5&vCount=12&vKind=1
143,2019-03-21,SK바이오팜수면장애신약솔리암페톨美FDA승인,http://www.newsway.co.kr/news/view?tp=1&ud=2019032109305390604
144,2019-03-21,SK바이오팜수면장애신약美FDA승인,http://view.asiae.co.kr/news/view.htm?idxno=2019032109333548606
145,2019-03-21,종합SK바이오팜수면장애신약솔리암페톨미국FDA승인,http://www.newspim.com/news/view/20190321000183
146,2019-03-21,SK바이오팜기술수출한수면장애신약FDA판매승인종합,http://yna.kr/AKR20190321032251008?did=1195m
147,2019-03-21,SK바이오팜수면장애신약솔리암페톨미FDA승인,http://www.etnews.com/20190321000027
148,2019-03-21,SK바이오팜美FDA서수면장애신약솔리암페톨시판허가받아,http://news.mk.co.kr/newsRead.php?year=2019&no=169993
149,2019-03-21,SK바이오팜수면장애신약솔리암페톨美FDA승인,http://www.metroseoul.co.kr/news/newsview?newscd=2019032100024
150,2019-03-21,SK바이오팜수면장애신약솔리암페톨미FDA승인,http://news.hankyung.com/article/2019032179546
151,2019-03-21,SK바이오팜수면장애신약솔리암페톨美FDA승인,http://news.heraldcorp.com/view.php?ud=20190321000184
152,2019-03-21,SK바이오팜수면장애신약솔리암페톨FDA승인,http://www.asiatime.co.kr/news/articleView.html?idxno=235033
153,2019-03-21,SK바이오팜개발수면장애신약솔리암페톨미국판매허가,http://www.seoulfn.com/news/articleView.html?idxno=337291
154,2019-03-21,SK바이오팜수면장애신약솔리암페톨美FDA시판허가,http://news1.kr/articles/?3576497
155,2019-03-21,SK바이오팜수면장애신약美FDA승인,http://www.sisafocus.co.kr/news/articleView.html?idxno=205234
156,2019-03-21,SK바이오팜수면장애신약솔리암페톨美FDA승인,http://www.upinews.kr/news/newsview.php?ncode=1065574219810242
157,2019-03-21,SK바이오팜수면장애신약美FDA승인글로벌종합제약사도약첫발,http://www.asiatoday.co.kr/view.php?key=20190321010012676
158,2019-03-21,SK바이오팜수면장애신약솔리암페톨美FDA허가획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1736211
159,2019-03-21,SK바이오팜수면장애신약솔리암페톨미국FDA승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228479
160,2019-03-21,SK바이오팜기술수출한솔리암페톨美FDA시판허가,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019032109553037670
161,2019-03-21,SK바이오팜수면장애신약솔리암페톨美FDA승인,http://news.mt.co.kr/mtview.php?no=2019032109481336944
162,2019-03-21,SK바이오팜수면장애신약솔리암페톨美FDA승인,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=004&oid=050&aid=0000049995
163,2019-03-21,SK바이오팜수면장애신약美허가국내중추신경계신약최초”,http://biz.chosun.com/site/data/html_dir/2019/03/21/2019032100881.html
164,2019-03-21,SK바이오팜신약개발의지통했다솔리암페톨美허가,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1066481
165,2019-03-21,SK바이오팜수면장애신약솔리암페톨美FDA승인,http://news.mk.co.kr/newsRead.php?year=2019&no=170194
166,2019-03-21,SK바이오팜기술수출한수면장애신약FDA판매승인,http://www.asiatoday.co.kr/view.php?key=20190321010012740
167,2019-03-21,SK바이오팜수면장애신약솔리암페톨FDA승인,http://www.econovill.com/news/articleView.html?idxno=359102
168,2019-03-21,SK바이오팜수면장애신약솔리암페톨美FDA승인,http://biz.newdaily.co.kr/site/data/html/2019/03/21/2019032100047.html
169,2019-03-21,SK바이오팜기술수출수면장애신약미국FDA승인,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903210185&t=NN
170,2019-03-21,SK바이오팜수면장애치료신약솔리암페톨美FDA승인,http://www.newsis.com/view/?id=NISX20190321_0000594455&cID=13001&pID=13000
171,2019-03-21,SK바이오팜수면장애신약솔리암페톨美FDA서시판허가,http://www.newsworks.co.kr/news/articleView.html?idxno=345438
172,2019-03-21,SK바이오팜수면장애신약솔리암페톨FDA승인받아,http://www.kpanews.co.kr/article/show.asp?idx=202399&table=article&category=D
173,2019-03-21,SK바이오팜수면장애신약솔리암페톨美FDA승인,http://www.viva100.com/main/view.php?key=20190321010007198
174,2019-03-21,SK바이오팜기술수출수면장애신약수노시美허가,http://www.medisobizanews.com/news/articleView.html?idxno=58581
175,2019-03-21,SK바이오팜기술수출수면장애신약美FDA판매승인,http://www.opinionnews.co.kr/news/articleView.html?idxno=14617
176,2019-03-21,SK바이오팜수면장애신약솔리암페톨美승인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=84666
177,2019-03-21,SK바이오팜수면장애신약美FDA승인,http://news.hankyung.com/article/201903218532f
178,2019-03-21,SK바이오팜솔리암페톨美FDA시판허가,http://news.heraldcorp.com/view.php?ud=20190321000380
179,2019-03-21,SK바이오팜수면장애신약솔리암페톨美FDA승인,http://www.bosa.co.kr/news/articleView.html?idxno=2101679
180,2019-03-21,SK바이오팜수면장애신약솔리암페톨美FDA시판허가,http://www.mdtoday.co.kr/mdtoday/index.html?no=349511
181,2019-03-21,미국시장뚫은SK바이오팜신약최태원26년바이오투자결실,http://www.newspim.com/news/view/20190321000339
182,2019-03-21,SK바이오팜수면장애신약美허가7월판매,http://news1.kr/articles/?3576734
183,2019-03-21,첫미국시장진출SK바이오팜26년신약개발결실,http://www.dailypharm.com/Users/News/NewsView.html?ID=250679&REFERER=NP
184,2019-03-21,SK바이오팜쾌거기면증신약美승인,http://www.munhwa.com/news/view.html?no=2019032101071639176001
185,2019-03-21,SK바이오팜수면장애신약솔리암페톨美FDA승인,http://www.newsprime.co.kr/news/article.html?no=451858
186,2019-03-21,SK바이오팜수면장애신약美FDA시판허가받아,https://www.nocutnews.co.kr/news/5122176
187,2019-03-21,SK바이오팜미국에서수면장애치료제신약판매허가받아,http://www.businesspost.co.kr/BP?command=article_view&num=119459
188,2019-03-21,SK바이오팜미국진출로SK기업가치견인전망,http://www.skyedaily.com/news/news_view.html?ID=82988
189,2019-03-21,사설SK바이오팜쾌거최태원의뚝심,http://www.etnews.com/20190321000336
190,2019-03-21,SK바이오팜글로벌신약탄생솔리암페톨수면장애시장선두목표,http://biz.newdaily.co.kr/site/data/html/2019/03/21/2019032100140.html
191,2019-03-21,SK바이오팜수면장애신약솔리암페톨美FDA시판허가,http://www.ajunews.com/view/20190321171109370
192,2019-03-21,SK바이오팜수면장애신약FDA판매허가,http://news.mk.co.kr/newsRead.php?year=2019&no=171929
193,2019-03-21,SK바이오팜수면장애신약수노시미국허가종합,http://www.edaily.co.kr/news/newspath.asp?newsid=03958966622425616
194,2019-03-21,SK바이오팜신약개발RD의힘수면장애치료제FDA시판승인,http://www.dt.co.kr/contents.html?article_no=2019032202101531102001&ref=naver
195,2019-03-21,SK바이오팜수면장애신약솔리암페톨FDA승인,http://www.hankookilbo.com/news/npath/201903211786774569?did=NA
196,2019-03-21,SK바이오팜수면장애신약솔리암페톨美FDA승인,http://news.kmib.co.kr/article/view.asp?arcid=0924068679&code=11151400&cp=nv
197,2019-03-22,SK바이오팜기술수출신약美식품의약국판매승인받아,http://www.seoul.co.kr/news/newsView.php?id=20190322022010&wlog_tag3=naver
198,2019-03-22,코스피코스닥21일주요공시SKSK바이오팜기술수출신약FDA판매승인등,http://www.betanews.net:8080/article/988886.html
199,2019-03-22,SK바이오팜수면장애신약FDA판매승인,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003526295
200,2019-03-22,I리포트SKSK바이오팜신약허가긍정적KB證,http://www.inews24.com/view/1165685
201,2019-03-22,SK주가상승동력확보자회사SK바이오팜사업안정화,http://www.businesspost.co.kr/BP?command=article_view&num=119631
202,2019-03-22,SK바이오팜수면장애신약솔리암페톨美FDA시판허가,http://www.kukinews.com/news/article.html?no=644091
203,2019-03-22,SK바이오팜성과에LG코오롱삼성제약사업투자조명,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019032210092600997&objId=A2019032210092600997&portalCode=naver
204,2019-03-22,SK바이오팜수면장애치료제美FDA허가쾌거,http://www.dailymedi.com/detail.php?number=841210&thread=22r05
205,2019-03-22,SK바이오팜수면장애신약미FDA승인,http://kormedi.com/?p=1284904
206,2019-03-22,SK바이오팜수면장애신약솔리암페톨美FDA승인,http://www.wsobi.com/news/articleView.html?idxno=71161
207,2019-03-23,제약바이오한주간이모저모SK바이오팜기면증치료제美FDA허가등,http://www.edaily.co.kr/news/newspath.asp?newsid=01482566622426272
208,2019-03-25,SK바이오팜수면장애신약솔리암페톨美FDA승인,http://www.dailysportshankook.co.kr/news/articleView.html?idxno=206665
209,2019-03-27,단독최태원의야심작SK바이오팜상장추진,http://news.mk.co.kr/newsRead.php?year=2019&no=183453
210,2019-03-27,InvestSK바이오팜IPO주관사선정절차착수,http://www.investchosun.com/?p=3236044
211,2019-03-27,SK바이오팜상장추진,http://www.etoday.co.kr/news/section/newsview.php?idxno=1738447
212,2019-03-27,최태원보물SK바이오팜코스피상장연내마무리,http://moneys.mt.co.kr/news/mwView.php?no=2019032709478079045
213,2019-03-27,SK바이오팜나스닥대신IPO절차돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=350070
214,2019-03-27,SKSK바이오팜상장땐특별배당이슈KB증권,http://www.choicenews.co.kr/news/articleView.html?idxno=49202
215,2019-03-27,SK바이오팜나스닥서코스피로선회연내상장추진,http://news.mt.co.kr/mtview.php?no=2019032710144219150
216,2019-03-27,바이오기대주SK바이오팜상장위한주관사물색,http://www.newstomato.com/ReadNews.aspx?no=884857
217,2019-03-27,더벨SK바이오팜RFP발송IPO닻올렸다,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201903260100047240002986
218,2019-03-27,SK의미래먹거리SK바이오팜상장추진,http://www.newspost.kr/news/articleView.html?idxno=70010
219,2019-03-27,SK바이오팜코스피상장추진하반기결정된다,http://www.seoulwire.com/news/articleView.html?idxno=97913
220,2019-03-27,마켓인사이트SK바이오팜유가증권시장상장추진주관사선정착수,http://news.hankyung.com/article/201903271245u
221,2019-03-27,수면장애신약결실SK바이오팜코스피상장추진,http://www.polinews.co.kr/news/article.html?no=386590
222,2019-03-27,SK바이오팜상장추진시총5조기대,http://www.upinews.kr/news/newsview.php?ncode=1065593027868985
223,2019-03-27,조정우SK바이오팜상장서둘러중추신경계치료제속도붙여,http://www.businesspost.co.kr/BP?command=article_view&num=120414
224,2019-03-27,최태원회장의바이오결실IPO추진SK바이오팜어떤회사,http://www.newsway.co.kr/news/view?tp=1&ud=2019032716570389234
225,2019-03-28,더벨SK바이오팜나스닥상장포기한배경은,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201903270100049440003122
226,2019-03-28,SK바이오팜상장추진기업가치최대6조원대,http://www.newsway.co.kr/news/view?tp=1&ud=2019032709455640561
227,2019-03-28,SK바이오팜상장에반색한국거래소SK바이오팜코스피상장요건충분”,http://www.viva100.com/main/view.php?key=20190328010009919
228,2019-03-28,코스피상장추진SK바이오팜신약가치로시총5조원이상전망,http://biz.newdaily.co.kr/site/data/html/2019/03/28/2019032800126.html
229,2019-03-28,대어급SK바이오팜상장주관사되기위해증권사경쟁치열,http://www.businesspost.co.kr/BP?command=article_view&num=120652
230,2019-03-29,SK바이오팜상장추진시총6조바이오사예고,http://www.dailymedi.com/detail.php?number=841442&thread=22r05
231,2019-03-29,SK바이오팜연내코스피상장추진시총5조바이오상장사탄생,http://www.ekn.kr/news/article.html?no=423209
232,2019-03-29,SK바이오팜연내코스닥상장추진,http://www.news2day.co.kr/123793
233,2019-04-01,최태원의야심작SK바이오팜코스피연내상장,http://weekly.hankooki.com/lpage/economy/201904/wk20190401103710146420.htm
234,2019-04-02,InvestSK바이오팜몸값5조이상최대7조평가이름값블록버스터기대감,http://www.investchosun.com/?p=3236242
235,2019-04-03,RD투자늘린바이오제약제일SK바이오팜50↑,http://www.biospectator.com/view/news_view.php?varAtcId=7396
236,2019-04-03,더벨SK바이오팜IPO속도RFP수령이틀만에PT,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201904020100004260000269
237,2019-04-03,바이오IPO대어잡자SK바이오팜놓고증권사격돌,http://news.mt.co.kr/mtview.php?no=2019040315163639051
238,2019-04-05,SK바이오팜경력사원회계관리채용접수9일까지 ,http://www.veritas-a.com/news/articleView.html?idxno=149490
239,2019-04-05,SK주가3거래일째상승SK텔레콤SK바이오팜호재많아,http://www.businesspost.co.kr/BP?command=article_view&num=121963
240,2019-04-09,마켓인사이트SK바이오팜IPO대표주관사로NH투자증권선정이르면연내상장,https://www.hankyung.com/article/201904096569u
241,2019-04-09,SK바이오팜IPO주관사NH證한국투자증권선정,http://news.mt.co.kr/mtview.php?no=2019040915342162464
242,2019-04-09,InvestSK바이오팜IPO대표주관사에NH證벌써부터고평가논란,http://www.investchosun.com/?p=3236450
243,2019-04-09,레이더MSK바이오팜IPO대표주간사NH證,http://news.mk.co.kr/newsRead.php?year=2019&no=217890
244,2019-04-09,기업가치5조SK바이오팜IPO주관사NH투자證선정,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019040916423587389
245,2019-04-09,fn마켓워치SK바이오팜IPO대표주관에NH투자증권,http://www.fnnews.com/news/201904091644462151
246,2019-04-09,시그널SK바이오팜IPO대표주관사NH투자증권연내상장추진,https://www.sedaily.com/NewsView/1VHSRU5KDV
247,2019-04-09,마켓인사이트기업공개대표주관사로NH證선정SK바이오팜이르면연내상장,https://www.hankyung.com/article/2019040974231
248,2019-04-09,NH투자증권조단위SK바이오팜IPO대표주관사선정,http://www.sisajournal-e.com/news/articleView.html?idxno=198405
249,2019-04-09,SK바이오팜업무대표주관사NH투자증권선정,http://www.mdtoday.co.kr/mdtoday/index.html?no=351380
250,2019-04-09,SK바이오팜IPO대표주관사NH투증연내코스피입성목표,http://www.fetv.co.kr/news/article.html?no=25462
251,2019-04-09,SK바이오팜IPO대표주관사에NH투자증권,http://news1.kr/articles/?3593179
252,2019-04-09,SK바이오팜IPO대표주관사에NH투자증권,http://www.fntoday.co.kr/news/articleView.html?idxno=186036
253,2019-04-09,IPO추진SK바이오팜대표주관사에NH투자증권,http://www.newspim.com/news/view/20190409000940
254,2019-04-10,더벨SK바이오팜IPO주관사에NH한국증권낙점,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201904090100016980001045
255,2019-04-10,SK바이오팜IPO주간사선정,http://www.mdtoday.co.kr/mdtoday/index.html?no=351482
256,2019-04-10,SK바이오팜주식상장도전장유망제약바이오기업들연내상장준비,http://www.dailysmart.co.kr/news/articleView.html?idxno=8932
257,2019-04-10,NH투자증권SK바이오팜상장주관해1위회복기회잡아,http://www.businesspost.co.kr/BP?command=article_view&num=122575
258,2019-04-11,SK바이오팜IPO시동SK바이오사업순풍,http://www.ebn.co.kr/news/view/980347
259,2019-04-11,더벨SK바이오팜IPO일정속도내는이유,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201904090100018460001140
260,2019-04-11,더벨SK바이오팜IPO주관SKCC가연결고리,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201904100100020870001281
261,2019-04-12,SKSK바이오팜IPO로1兆이상유동성확보할듯,http://view.asiae.co.kr/news/view.htm?idxno=2019041210150599905
262,2019-04-14,SKSK바이오팜IPO서두른다연내상장추진,http://www.mdtoday.co.kr/mdtoday/index.html?no=351794
263,2019-04-15,연내상장속도내는SK바이오팜세노바메이트본격상업화실탄마련,http://www.ekn.kr/news/article.html?no=426438
264,2019-04-16,더벨SK바이오팜IPONH씨티대표주관체제구축,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201904150100027640001705
265,2019-04-16,SK주식사도된다SKES좋고SK바이오팜성장기대,http://www.businesspost.co.kr/BP?command=article_view&num=123333
266,2019-04-17,최대어SK바이오팜부터재수생젠바디까지올20곳출사표,https://www.sedaily.com/NewsView/1VHWHLP3H0
267,2019-04-18,SK바이오팜美사와비소세포폐암치료제공동개발,http://www.medical-tribune.co.kr/news/articleView.html?idxno=85189
268,2019-04-18,SK바이오팜미국투자아와비소세포폐암혁신신약개발공동연구계약체결,http://www.fnnews.com/news/201904180916011725
269,2019-04-18,SK바이오팜미국AI기업과NSCLC신약공동RD계약체결,http://www.econovill.com/news/articleView.html?idxno=361199
270,2019-04-18,SK바이오팜美AI신약개발사와항암신약공동연구,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019041809085977829
271,2019-04-18,SK바이오팜美투자아社비소세포폐암치료제공동연구,http://www.ebn.co.kr/news/view/981330
272,2019-04-18,SK바이오팜美twoXAR와인공지능폐암신약공동연구,http://www.biospectator.com/view/news_view.php?varAtcId=7485
273,2019-04-18,SK바이오팜미국AI기업과폐암신약공동개발착수,http://www.dailypharm.com/Users/News/NewsView.html?ID=251736&REFERER=NP
274,2019-04-18,SK바이오팜미국투자아폐암신약공동연구계약체결,http://yna.kr/AKR20190418043800017?did=1195m
275,2019-04-18,SK바이오팜미국투자아와비소세포폐암신약공동연구계약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=229574
276,2019-04-18,SK바이오팜美투자아사와인공지능기반신약공동개발맞손,http://news1.kr/articles/?3600242
277,2019-04-18,SK바이오팜美신약개발회사와치료혁직신약개발공동연구계약체결,http://www.sisafocus.co.kr/news/articleView.html?idxno=207763
278,2019-04-18,SK바이오팜美AI기반바이오텍과함께폐암치료제개발키로,http://news.mk.co.kr/newsRead.php?year=2019&no=240623
279,2019-04-18,SK바이오팜美투자아와AI활용한폐암신약개발공동연구,http://view.asiae.co.kr/news/view.htm?idxno=2019041809391849658
280,2019-04-18,SK바이오팜美투자아사와폐암신약공동개발협약체결,http://www.edaily.co.kr/news/newspath.asp?newsid=01994246622457432
281,2019-04-18,SK바이오팜美투자아와비소세포폐암혁신신약공동연구계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=352186
282,2019-04-18,SK바이오팜미국투자아와비소세포폐암혁신신약개발,http://biz.chosun.com/site/data/html_dir/2019/04/18/2019041801033.html
283,2019-04-18,SK바이오팜AI기술로비소세포폐암신약개발美투자아와공동연구계약,http://www.etoday.co.kr/news/section/newsview.php?idxno=1746509
284,2019-04-18,SK바이오팜인공지능기술로차세대항암신약개발본격화,http://medipana.com/news/news_viewer.asp?NewsNum=237704&MainKind=A&NewsKind=5&vCount=12&vKind=1
285,2019-04-18,SK바이오팜미국투자아와비소세포폐암신약개발공동연구계약,http://www.newsway.co.kr/news/view?tp=1&ud=2019041809464215010
286,2019-04-18,SK바이오팜美투자아社비소세포폐암혁신신약개발공동연구계약체결,http://www.asiatime.co.kr/news/articleView.html?idxno=240731
287,2019-04-18,SK바이오팜미국AI바이오텍과항암제공동개발,http://news.einfomax.co.kr/news/articleView.html?idxno=4026169
288,2019-04-18,SK바이오팜미국투자아社와AI기반폐암신약개발계약,http://www.medisobizanews.com/news/articleView.html?idxno=59175
289,2019-04-18,SK바이오팜美AI신약개발회사와비소세포폐암치료제공동연구,http://www.newspim.com/news/view/20190418000209
290,2019-04-18,SK바이오팜美투자아와비소세포폐암신약공동개발계약,http://www.metroseoul.co.kr/news/newsview?newscd=2019041800034
291,2019-04-18,SK바이오팜美업체와폐암신약공동연구계약,https://www.sedaily.com/NewsView/1VHWVORCCE
292,2019-04-18,SK바이오팜美와AI기반비소세포폐암신약공동연구,http://news.heraldcorp.com/view.php?ud=20190418000250
293,2019-04-18,SK바이오팜미국투자아社와공동연구계약체결,http://www.bosa.co.kr/news/articleView.html?idxno=2103652
294,2019-04-18,SK바이오팜AI기반비소세포폐암신약개발박차,http://news.mt.co.kr/mtview.php?no=2019041809122458673
295,2019-04-18,SK바이오팜미국바이오텍과폐암신약공동개발 ,http://www.seoulfn.com/news/articleView.html?idxno=340253
296,2019-04-18,SK바이오팜투자아와비소세포폐암치료제개발협약,http://www.dailysmart.co.kr/news/articleView.html?idxno=9405
297,2019-04-18,SK바이오팜美투자아와비소세포폐암신약개발공동연구,http://biz.newdaily.co.kr/site/data/html/2019/04/18/2019041800075.html
298,2019-04-18,SK바이오팜미국투자아와비소세포페암혁신신약공동연구계약체결,http://www.newstomato.com/ReadNews.aspx?no=889822
299,2019-04-18,SK바이오팜비소세포폐암신약美공동연구,http://news.heraldcorp.com/view.php?ud=20190418000473
300,2019-04-18,SK바이오팜美투자아와비소세포폐암신약공동연구나서,http://moneys.mt.co.kr/news/mwView.php?no=2019041813228030402
301,2019-04-18,SK바이오팜미국투자아와AI기반폐암신약공동개발협약,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201904180310&t=NN
302,2019-04-18,SK바이오팜미국기업과인공지능활용한폐암신약공동개발,http://www.businesspost.co.kr/BP?command=article_view&num=123712
303,2019-04-18,SK바이오팜미국AI바이오기업과폐암혁신신약개발공동연구,https://www.hankyung.com/article/201904189035f
304,2019-04-18,SK바이오팜미국투자아社와비소세포폐암혁신신약개발공동연구계약체결,http://news.mk.co.kr/newsRead.php?year=2019&no=241714
305,2019-04-18,SK바이오팜미투자아비소세포폐암치료제공동연구키로,http://www.kpanews.co.kr/article/show.asp?idx=203267&table=article&category=D
306,2019-04-18,SK바이오팜미국투자아와폐암신약공동연구계약체결,http://www.nextdaily.co.kr/news/article.html?id=20190418800043
307,2019-04-18,SK바이오팜미국투자아와비소세포폐암혁신신약개발공동연구계약체결,http://www.etnews.com/20190418000364
308,2019-04-18,SK바이오팜美회사와세포폐암신약공동연구,http://www.dt.co.kr/contents.html?article_no=2019041902101531102002&ref=naver
309,2019-04-24,희비엇갈리는SK제약바이오형제SK바이오팜형보다나은아우될까,http://www.asiatoday.co.kr/view.php?key=20190423010015936
310,2019-04-24,희비갈린SK바이오팜과SK케미칼,http://www.dailymedi.com/detail.php?number=842359&thread=22r05
311,2019-04-24,엇갈린표정짓는SK바이오팜과SK케미칼,http://www.mdtoday.co.kr/mdtoday/index.html?no=352710
312,2019-04-26,더벨SK매직SK바이오팜에밀려IPO연기,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201904240100045100002802
313,2019-05-03,더벨SK바이오팜RD에연간1000억소진IPO가나,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201905020100000790000048
314,2019-05-07,SK바이오자회사SK바이오팜성장에힘입어기업가치높아져,http://www.businesspost.co.kr/BP?command=article_view&num=126139
315,2019-05-10,SK바이오팜美신경과학회학술대회서뇌전증신약알리기나서,http://biz.chosun.com/site/data/html_dir/2019/05/10/2019051000834.html
316,2019-05-10,SK바이오팜미국신경과학회연례학술대회참가,http://www.fnnews.com/news/201905100929471762
317,2019-05-10,SK바이오팜미국신경과학회연례학술대회참가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230316
318,2019-05-10,SK바이오팜美신경과학회서뇌전증질환인식제고캠페인나서,http://news.mk.co.kr/newsRead.php?year=2019&no=307343
319,2019-05-10,뇌전증신약개발한SK바이오팜美신경과학회연례학술대회참가,https://www.sedaily.com/NewsView/1VJ34Z1P6H
320,2019-05-10,SK바이오팜미국신경과학회연례학술대회서발표,http://news.mk.co.kr/newsRead.php?year=2019&no=307373
321,2019-05-10,SK바이오팜미국서뇌전증신약후보물질임상결과발표,http://www.ebn.co.kr/news/view/984268
322,2019-05-10,SK바이오팜미국AAN서뇌전증신약세노바메이트임상결과발표,http://www.econovill.com/news/articleView.html?idxno=362771
323,2019-05-10,SK바이오팜미국신경과학회연례학술대회참가,http://www.newsway.co.kr/news/view?tp=1&ud=2019051009265222388
324,2019-05-10,SK바이오팜미국신경과학회서세노바메이트연구발표,http://medipana.com/news/news_viewer.asp?NewsNum=238724&MainKind=A&NewsKind=5&vCount=12&vKind=1
325,2019-05-10,SK바이오팜美신경과학회학술대회서뇌전증신약세노바메이트임상결과발표,http://biz.newdaily.co.kr/site/data/html/2019/05/10/2019051000040.html
326,2019-05-10,SK바이오팜美신경과학회학술대회서신약임상결과발표,http://www.asiatoday.co.kr/view.php?key=20190510010005845
327,2019-05-10,SK바이오팜미국신경과학회연례학술대회참가,http://www.bosa.co.kr/news/articleView.html?idxno=2104897
328,2019-05-10,SK바이오팜美학술대회참가뇌전증인식제고캠페인,http://www.dailysmart.co.kr/news/articleView.html?idxno=10553
329,2019-05-10,SK바이오팜美신경과학회연례학술대회서뇌전증신약소개,http://www.newsis.com/view/?id=NISX20190510_0000646578&cID=13001&pID=13000
330,2019-05-10,SK바이오팜美신경과학회서뇌전증약세노바메이트임상결과발표,http://www.edaily.co.kr/news/newspath.asp?newsid=03102886622487608
331,2019-05-10,SK바이오팜미국신경과학회서기술력과시뇌전증약임상발표,http://moneys.mt.co.kr/news/mwView.php?no=2019051011208011646
332,2019-05-10,SK바이오팜미국신경과학회연례학술대회참가,http://www.metroseoul.co.kr/news/newsview?newscd=2019051000038
333,2019-05-10,SK바이오팜美신경과학회연례학술대회참가,https://view.asiae.co.kr/news/view.htm?idxno=2019051014242115190
334,2019-05-10,SK바이오팜미국신경과학회연례학술대회참가,http://www.etnews.com/20190510000413
335,2019-05-10,SK바이오팜美신경과학회연례학술대회참가뇌전증신약소개,http://www.seoulwire.com/news/articleView.html?idxno=127616
336,2019-05-10,SK바이오팜美학술대회서세노바메이트임상결과발표,http://www.techholic.co.kr/news/articleView.html?idxno=182264
337,2019-05-10,SK바이오팜미국신경학회에서뇌전증신약임상결과발표,http://www.businesspost.co.kr/BP?command=article_view&num=126731
338,2019-05-10,SK바이오팜미국신경과학회연례학술대회참가,http://www.mdtoday.co.kr/mdtoday/index.html?no=354196
339,2019-05-10,SK바이오팜미국신경과학회연례학술대회참가,http://www.kpanews.co.kr/article/show.asp?idx=203815&table=article&category=D
340,2019-05-10,SK바이오팜ANN연례학술대회참가세노바메이트임상결과발표,http://www.asiatime.co.kr/news/articleView.html?idxno=244844
341,2019-05-14,핫해하테새내기주대어급없다고SK바이오팜KCFT자이SD주목,http://www.ekn.kr/news/article.html?no=431919
342,2019-05-16,SK주가상승예상비상장자회사선전에SK바이오팜상장추진,http://www.businesspost.co.kr/BP?command=article_view&num=127508
343,2019-05-21,더벨SK바이오팜기업가치5조뇌전증치료제성장관건,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201905170100030890001934
344,2019-05-24,조정우SK바이오팜사장미국서살다시피신약챙긴다,http://www.ajunews.com/view/20190523145515768
345,2019-05-24,더벨SK바이오팜IPO속도조절,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201905220100038130002376
346,2019-05-24,연내상장앞둔SK바이오팜뇌전증신약새로운성장동력되나,http://www.ekn.kr/news/article.html?no=433738
347,2019-05-24,SK주가반등가능SK바이오팜상장되면기업가치커져,http://www.businesspost.co.kr/BP?command=article_view&num=128643
348,2019-05-27,SK바이오팜레녹스가스토증후군치료제개발박차2023년내허가신청,http://www.ceoscoredaily.com/news/article.html?no=55992
349,2019-06-04,코오롱삼성바이오울고SK바이오팜LG화학웃고,http://www.dailymedi.com/detail.php?number=843779&thread=22r05
350,2019-06-04,리포트브리핑SKSK에는SK바이오팜만있는것이아니다목표가360000원KB증권,http://www.newspim.com/news/view/20190604000181
351,2019-06-04,NH투자증권SK바이오팜상장연기가능성에아쉬움100배,http://www.businesspost.co.kr/BP?command=article_view&num=130168
352,2019-06-10,SK바이오팜뇌전증신약적응증확대시동,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019061015574802636&objId=A2019061015574802636&portalCode=naver
353,2019-06-19,SK바이오팜수면장애신약내달초부터미국시장판매돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=357772
354,2019-06-20,SK바이오팜기술수출수면장애신약내달미국서시판,http://yna.kr/AKR20190619153600017?did=1195m
355,2019-06-20,SK바이오팜기술수출한수면장애신약7월美시판,http://news.heraldcorp.com/view.php?ud=20190620000035
356,2019-06-20,SK바이오팜의솔리암페톨다음달미국서판매개시,http://news.mk.co.kr/newsRead.php?year=2019&no=437523
357,2019-06-20,SK바이오팜수면장애신약내달미국서시판,http://www.seoulwire.com/news/articleView.html?idxno=156940
358,2019-06-20,SK바이오팜수면장애신약솔리암페톨내달미국출시,http://www.newspim.com/news/view/20190620000221
359,2019-06-20,SK바이오팜기술수출수면장애신약내달미국출시,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019062010070038999
360,2019-06-20,SK바이오팜개발수면장애신약내달美시판,http://news.heraldcorp.com/view.php?ud=20190620000342
361,2019-06-20,SK바이오팜수면장애신약솔리암페톨7월美시판,http://www.ebn.co.kr/news/view/989822
362,2019-06-20,SK바이오팜수면장애신약미국시판,http://www.naeil.com/news_view/?id_art=316900
363,2019-06-20,SK바이오팜기술수출수면장애신약내달미국서시판,http://www.etnews.com/20190620000138
364,2019-06-20,SK바이오팜기술수출한수면장애신약7월미국출시,http://www.metroseoul.co.kr/news/newsview?newscd=2019062000170
365,2019-06-20,조정우SK바이오팜수면장애신약시작으로미국공략본격화,http://www.businesspost.co.kr/BP?command=article_view&num=132259
366,2019-06-21,SK바이오팜자체개발수면장애신약7월美시판,http://www.sporbiz.co.kr/news/articleView.html?idxno=349165
367,2019-06-21,SK바이오팜솔리암페톨글로벌블록버스터가될수있을까,http://www.g-enews.com/ko-kr/news/article/news_all/2019062110322865669d76442fa_1/article.html
368,2019-06-21,성과내는SK바이오팜LG화학광폭행보주목,http://www.ebn.co.kr/news/view/990084
369,2019-06-24,바이오IPO꿈틀SK바이오팜주목,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201906240233&t=NNv
370,2019-06-27,바이오기업최대어SK바이오팜하반기코스피입성성공할까,http://www.insightkorea.co.kr//news/articleView.html?idxno=42532
371,2019-06-28,SK바이오팜부광약품CNS신약개발에박차,http://www.mdtoday.co.kr/mdtoday/index.html?no=358495
372,2019-06-28,특징주유바이오로직스SK바이오팜등대형제약사에주당1만5000원매각추진강세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1771291
373,2019-06-28,특징주유바이오SK바이오팜등국내외제약사들군침주당1만5000원,https://view.asiae.co.kr/article/2019062810352228388
374,2019-06-30,SK바이오팜지난해상표권사용료1억7000만원전년비2감소,http://www.ceoscoredaily.com/news/article.html?no=57309
375,2019-07-01,바이오사악재폭탄에IPO눈치SK바이오팜이름값할까,http://www.dailian.co.kr/news/view/806789/?sc=naver
376,2019-07-01,SK바이오팜K바이오주역으로떠오른다,http://www.news2day.co.kr/130831
377,2019-07-03,SK바이오팜기면증치료제솔리암페톨이달8일미국첫출시,http://www.edaily.co.kr/news/newspath.asp?newsid=02223846622550912
378,2019-07-03,SK바이오팜수면장애신약솔리암폐톨미국시장본격발매,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232396
379,2019-07-03,SK바이오팜수면장애신약美본격발매SK의26년신약RD쾌거,http://www.segye.com/content/html/2019/07/03/20190703504311.html?OutUrl=naver
380,2019-07-03,SK바이오팜수면장애신약세계최대시장미국서본격발매,http://biz.chosun.com/site/data/html_dir/2019/07/03/2019070300849.html
381,2019-07-03,SK바이오팜기술수출한수면장애신약미국본격발매,http://medipana.com/news/news_viewer.asp?NewsNum=242297&MainKind=A&NewsKind=5&vCount=12&vKind=1
382,2019-07-03,SK바이오팜기술수출수면장애신약이달8일美출시,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019070309584358331
383,2019-07-03,SK바이오팜수면장애신약솔리암페톨미국출시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1772862
384,2019-07-03,SK바이오팜중추신경계혁신신약美시장첫상륙,http://www.ebn.co.kr/news/view/991659
385,2019-07-03,SK바이오팜수면장애신약미국시장전격출시,http://www.newsis.com/view/?id=NISX20190703_0000699564&cID=13001&pID=13000
386,2019-07-03,SK바이오팜수면장애신약美대륙본격공략8일부터시판”,https://www.sedaily.com/NewsView/1VLJTUF6MO
387,2019-07-03,SK바이오팜수면장애신약솔리암페톨미국본격출시,http://www.newspim.com/news/view/20190703000313
388,2019-07-03,SK바이오팜수면장애신약솔리암페톨8일미국본격발매,http://www.sisafocus.co.kr/news/articleView.html?idxno=214072
389,2019-07-03,SK바이오팜수면장애신약8일부터미국약국서판매,http://news.heraldcorp.com/view.php?ud=20190703000234
390,2019-07-03,SK바이오팜수면장애신약솔리암페톨美발매,https://view.asiae.co.kr/article/2019070310275519166
391,2019-07-03,SK바이오팜수면장애신약미국시장전격출시,http://jedam15.koreafree.co.kr/news/view.html?section=1&category=3&item=&no=54464
392,2019-07-03,SK바이오팜수면장애신약솔리암페톨美발매,http://www.biospectator.com/view/news_view.php?varAtcId=7953
393,2019-07-03,SK바이오팜수면장애신약미국판매시작,http://www.inews24.com/view/1190798
394,2019-07-03,SK바이오팜수면장애신약미국약국서판다,http://news.mt.co.kr/mtview.php?no=2019070310325066749
395,2019-07-03,SK바이오팜수면장애신약미국본격발매,http://www.etnews.com/20190703000145
396,2019-07-03,SK바이오팜수면장애신약솔리암페톨미국서본격출시,http://www.econovill.com/news/articleView.html?idxno=366856
397,2019-07-03,SK바이오팜수면장애치료제美발매,http://www.medical-tribune.co.kr/news/articleView.html?idxno=86642
398,2019-07-03,SK바이오팜수면장애신약솔리암페톨8일美시판,http://www.dt.co.kr/contents.html?article_no=2019070302109931102003&ref=naver
399,2019-07-03,SK바이오팜수면장애신약솔리암페톨미국서첫발매,http://www.insightkorea.co.kr//news/articleView.html?idxno=43163
400,2019-07-03,SK바이오팜수면장애신약미국본격발매,http://www.mdtoday.co.kr/mdtoday/index.html?no=358928
401,2019-07-03,SK바이오팜수면장애신약미국본격발매,http://www.bosa.co.kr/news/articleView.html?idxno=2108236
402,2019-07-03,SK바이오팜수면장애신약솔리암페톨미국시판돌입,http://www.newstomato.com/ReadNews.aspx?no=905422
403,2019-07-03,SK바이오팜8일부터수면장애신약수노시미국서판매,http://news1.kr/articles/?3661260
404,2019-07-03,SK바이오팜수면장애신약미국본격발매,http://www.newsway.co.kr/news/view?tp=1&ud=2019070313405827236
405,2019-07-03,SK바이오팜수면장애신약오는8일미국발매,http://yna.kr/AKR20190703098500017?did=1195m
406,2019-07-03,SK바이오팜수면장애신약수노시美출시내주부터판매,http://www.medisobizanews.com/news/articleView.html?idxno=60864
407,2019-07-03,SK바이오팜수면장애신약미국진출할까,http://moneys.mt.co.kr/news/mwView.php?no=2019070313558028656
408,2019-07-03,SK바이오팜수면장애신약미국출시조정우세계최대시장첫발,http://www.businesspost.co.kr/BP?command=article_view&num=133904
409,2019-07-03,SK바이오팜수면장애신약솔리암페톨오는8일부터미국시판,http://biz.newdaily.co.kr/site/data/html/2019/07/03/2019070300067.html
410,2019-07-03,SK바이오팜수면장애신약이달8일美서출시,http://www.seoulwire.com/news/articleView.html?idxno=167416
411,2019-07-03,SK바이오팜수면장애신약오는8일미국발매,http://www.asiatoday.co.kr/view.php?key=20190703010002351
412,2019-07-03,SK바이오팜수면장애신약오는8일미국서본격발매,http://www.youthdaily.co.kr/news/articleView.html?idxno=12790
413,2019-07-03,SK바이오팜수면장애신약미국서본격발매,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907030472&t=NN
414,2019-07-03,SK바이오팜수면장애신약8일부터미국판매개시,http://www.metroseoul.co.kr/news/newsview?newscd=2019070300135
415,2019-07-03,SK바이오팜개발한수면장애혁신신약8일부터미국시판,http://news.mk.co.kr/newsRead.php?year=2019&no=483811
416,2019-07-03,SK바이오팜수면장애신약솔리암페톨미국발매,http://www.seoulfn.com/news/articleView.html?idxno=348114
417,2019-07-03,SK바이오팜수면장애신약미국본격발매,http://www.ajunews.com/view/20190703170919833
418,2019-07-03,SK바이오팜수면장애신약미국본격발매,https://jhealthmedia.joins.com/article/article_view.asp?pno=20599
419,2019-07-03,SK바이오팜수면장애신약美시장본격진출,http://www.fnnews.com/news/201907031834370158
420,2019-07-04,SK바이오팜수면장애신약미국본격발매,http://www.kpanews.co.kr/article/show.asp?idx=205200&table=article&category=D
421,2019-07-04,SK바이오팜수면장애신약솔리암페톨8일부터미국서시판,http://www.kukinews.com/news/article.html?no=678791
422,2019-07-08,SK자회사SK바이오팜SK바이오텍바이오사업으로기업가치상승,http://www.businesspost.co.kr/BP?command=article_view&num=134455
423,2019-07-10,더벨SK바이오팜IPO법률자문사지평태평양,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201907080100015680000979
424,2019-07-11,현대에너지SK바이오팜하반기IPO큰장선다,http://news.mk.co.kr/newsRead.php?year=2019&no=511670
425,2019-07-13,SK케미칼은바이오의약품SK바이오팜은케미칼의약품,https://www.sedaily.com/NewsView/1VLOF2CO5I
426,2019-07-15,SK바이오팜수면장애치료제수노시美기업에기술수출,https://www.sedaily.com/NewsView/1VLPDPZAZP
427,2019-07-18,SK바이오팜셀트리온K바이오하반기글로벌허가줄잇는다,http://www.etoday.co.kr/news/section/newsview.php?idxno=1777972
428,2019-07-19,SK주식상승전망자회사SKESSK건설SK바이오팜실적호조,http://www.businesspost.co.kr/BP?command=article_view&num=135990
429,2019-08-05,SK바이오팜하반기IPO나설까SK매직은내년가닥,http://news.mt.co.kr/mtview.php?no=2019080515115696866
430,2019-08-06,SK바이오팜하반기IPO등판여부주목,http://www.mdtoday.co.kr/mdtoday/index.html?no=361628
431,2019-08-06,바이오업계잇단악재SK바이오팜녹십자웰빙상장에악영향,http://www.finomy.com/news/articleView.html?idxno=68317
432,2019-08-07,사라진바이오프리미엄에⋯IPO대어SK바이오팜보로노이노심초사,http://www.dailian.co.kr/news/view/816251/?sc=naver
433,2019-08-10,SK바이오팜FDA허가솔리암페톨기술료3650만달러중일부수령,http://www.mdtoday.co.kr/mdtoday/index.html?no=362003
434,2019-08-14,단독최태원회장장녀최윤정씨SK바이오팜떠나美바이오유학,https://view.asiae.co.kr/article/2019081410545936737
435,2019-08-14,최태원회장장녀SK바이오팜휴직美바이오유학,http://www.newsway.co.kr/news/view?tp=1&ud=2019081411290312569
436,2019-08-14,최태원회장장녀최윤정씨SK바이오팜떠나美유학길,http://biz.chosun.com/site/data/html_dir/2019/08/14/2019081401479.html
437,2019-08-14,최태원회장장녀최윤정씨SK바이오팜떠나미국유학길,http://www.inews24.com/view/1201726
438,2019-08-14,최태원회장장녀최윤정씨SK바이오팜떠나美바이오유학,http://www.newsfc.co.kr/news/articleView.html?idxno=37450
439,2019-08-14,최태원SK회장장녀윤정씨SK바이오팜휴직美유학길오른다,http://www.edaily.co.kr/news/newspath.asp?newsid=03873686622587320
440,2019-08-14,최태원SK회장장녀최윤정씨美유학길올라마치는대로SK바이오팜복귀할듯,http://www.sisafocus.co.kr/news/articleView.html?idxno=218154
441,2019-08-14,최태원회장장녀SK바이오팜휴직생명정보학배우러유학길,http://news.einfomax.co.kr/news/articleView.html?idxno=4043641
442,2019-08-14,최태원SK회장장녀최윤정SK바이오팜부장미국유학길올라,https://www.sedaily.com/NewsView/1VMYTT5GDC
443,2019-08-14,최태원SK회장장녀최윤정씨SK바이오팜떠나美유학,http://www.donga.com/news/article/all/20190814/96967926/2
444,2019-08-14,최태원회장장녀최윤정씨SK바이오팜휴직美바이오유학길,http://www.kukinews.com/news/article.html?no=691839
445,2019-08-14,최태원회장장녀윤정씨SK바이오팜휴직하고미국유학길,http://www.viva100.com/main/view.php?key=20190814010004480
446,2019-08-14,최태원SK그룹회장장녀SK바이오팜떠난다美유학길,http://www.cstimes.com/?mod=news&act=articleView&idxno=312804
447,2019-08-14,최태원회장장녀SK바이오팜휴직美스탠포드대유학,http://www.ajunews.com/view/20190814162238670
448,2019-08-14,최태원SK회장장녀최윤정씨SK바이오팜떠나美유학,http://www.fetv.co.kr/news/article.html?no=34406
449,2019-08-14,최태원회장장녀SK바이오팜떠나美유학길차녀는SK하이닉스입사,http://www.donga.com/news/article/all/20190814/96971152/1
450,2019-08-14,최태원장녀SK바이오팜휴직유학차녀SK하이닉스입사,http://www.hani.co.kr/arti/economy/marketing/905774.html
451,2019-08-14,최태원회장장녀SK바이오팜휴직생명정보학배우러유학길종합,http://news.einfomax.co.kr/news/articleView.html?idxno=4043734
452,2019-08-14,최태원노소영장녀최윤정미국스탠퍼드대학교유학길올라2년후SK바이오팜복귀추측,http://www.newsinside.kr/news/articleView.html?idxno=979017
453,2019-08-16,SKSK바이오팜가치의향방과적극적인주주환원여부가주가반등의키”,http://www.wikitree.co.kr/main/news_view.php?id=454642
454,2019-08-18,바이오악재속구원투수로나선SK바이오팜,http://www.edaily.co.kr/news/newspath.asp?newsid=01741686622588632
455,2019-08-19,조정우SK바이오팜뇌전증신약허가와기업공개까지내달린다,http://www.businesspost.co.kr/BP?command=article_view&num=140009
456,2019-08-22,SK바이오팜연내상장추진SK㈜이사회서가결,http://yna.kr/AKR20190821145400003?did=1195m
457,2019-08-22,SK바이오팜개발기면증치료제수노시원래는실패한약,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1071489
458,2019-08-22,기업가치5조원평가SK바이오팜11월중순이후IPO추진,http://kpenews.com/View.aspx?No=87068
459,2019-08-22,SK바이오팜연내상장추진이사회통과,http://news.heraldcorp.com/view.php?ud=20190822000042
460,2019-08-22,SK바이오팜연내상장추진이사회서가결,http://www.sportsseoul.com/news/read/808316
461,2019-08-22,이사회절차마무리한SK바이오팜연내상장추진속도,http://www.newsway.co.kr/news/view?tp=1&ud=2019082209052699498
462,2019-08-22,SK바이오팜IPO추진기업가치5兆연내공모전망무게,http://www.seoulwire.com/news/articleView.html?idxno=202151
463,2019-08-22,SK바이오팜연내상장추진SK㈜이사회서가결,http://www.kukinews.com/news/article.html?no=693830
464,2019-08-22,SK바이오팜연내IPO추진한투NH證주관,http://www.kukinews.com/news/article.html?no=693827
465,2019-08-22,SK바이오팜뇌전증신약힘입어연내상장윤곽,http://www.mediasr.co.kr/news/articleView.html?idxno=54116
466,2019-08-22,SK바이오팜연내상장추진SK이사회서통과,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003693447
467,2019-08-22,SK바이오팜기업공개IPO연내추진,http://www.fntoday.co.kr/news/articleView.html?idxno=200081
468,2019-08-22,SK바이오팜상장하면SK㈜주주특별배당얼마나,http://news.heraldcorp.com/view.php?ud=20190822000211
469,2019-08-22,기업가치5조원SK바이오팜연내상장추진SK㈜이사회서가결,http://www.dt.co.kr/contents.html?article_no=2019082202109932781005&ref=naver
470,2019-08-22,SK바이오팜연내상장추진SK㈜이사회서가결,https://cnbc.sbs.co.kr/article_hub/10000952695?division=NAVER
471,2019-08-22,SK바이오팜연내기업공개추진,http://www.mdtoday.co.kr/mdtoday/index.html?no=362956
472,2019-08-22,SK바이오팜연내상장추진SK㈜이사회서가결,http://www.etnews.com/20190822000165
473,2019-08-22,IPO대어SK바이오팜연내상장추진SK이사회서가결,http://biz.chosun.com/site/data/html_dir/2019/08/22/2019082201526.html
474,2019-08-22,SK바이오팜연내상장추진,http://www.naeil.com/news_view/?id_art=323343
475,2019-08-22,SK이사회열고SK바이오팜의올해기업공개추진안건가결,http://www.businesspost.co.kr/BP?command=article_view&num=140515
476,2019-08-22,SK바이오팜연내IPO추진,http://www.fntimes.com/html/view.php?ud=2019082217350574897de3572ddd_18
477,2019-08-22,SK바이오팜연내상장바이오株약될까,http://news.mk.co.kr/newsRead.php?year=2019&no=654063
478,2019-08-22,올최대어SK바이오팜연내상장하나,https://www.hankyung.com/finance/article/2019082212371
479,2019-08-22,글로벌신약자신감SK바이오팜연내IPO,https://www.sedaily.com/NewsView/1VN2IQ8KNE
480,2019-08-22,기업가치5兆SK바이오팜연내상장속도낸다,http://www.dt.co.kr/contents.html?article_no=2019082302100932781005&ref=naver
481,2019-08-23,SK바이오팜신약카리스바메이트임상1상확대환자장기안전성확인,http://www.ceoscoredaily.com/news/article.html?no=59535
482,2019-08-23,더벨반토막난유통시장SK바이오팜몸값고심,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201908220100039350002425
483,2019-08-23,더벨SK바이오팜IPO예심청구고민되네,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201908220100039280002420
484,2019-08-23,NH투자증권대어SK바이오팜상장해올해주관실적1위지키나,http://www.businesspost.co.kr/BP?command=article_view&num=140738
485,2019-08-24,바이오株악재속글로벌신약자신감SK바이오팜연내IPO”,https://www.sedaily.com/NewsView/1VN3G6E79P
486,2019-08-26,SK바이오팜상장추진에이치엘비임상호재바이오株본격반등할까,http://www.ekn.kr/news/article.html?no=449741
487,2019-08-26,더벨적자SK바이오팜매출시총요건으로코스피타진,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201908230100040600002505
488,2019-08-26,더벨SK바이오팜루브리컨츠와닮은꼴공모구조고심,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201908230100040640002509
489,2019-08-26,SK바이오팜상장윤곽침체된바이오투심회복될까,http://www.newsis.com/view/?id=NISX20190826_0000750835&cID=13001&pID=13000
490,2019-08-26,더벨SK바이오팜세노바메이트허가IPO승인도좌우,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201908220100040080002474
491,2019-08-26,더벨최대어SK바이오팜연내증시입성가능성은,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201908220100040440002496
492,2019-08-26,SK바이오팜IPO추진바이오업계기대반우려반,http://www.finomy.com/news/articleView.html?idxno=68784
493,2019-08-27,SK바이오팜사외이사신규선임,http://www.newsway.co.kr/news/view?tp=1&ud=2019082715134647103
494,2019-08-27,SK바이오팜사외이사3명신규선임,http://www.segye.com/content/html/2019/08/27/20190827509075.html?OutUrl=naver
495,2019-08-27,SK바이오팜사외이사3인신규선임경영투명성업그레이드,http://www.ebn.co.kr/news/view/998657
496,2019-08-27,SK바이오팜사외이사에한국인최초FDA부국장출신등3명신규선임,https://www.sedaily.com/NewsView/1VN4SRRWF6
497,2019-08-27,SK바이오팜IPO위한조직재정비사외이사3명신규선임,http://www.metroseoul.co.kr/news/newsview?newscd=2019082700172
498,2019-08-27,SK바이오팜상장초읽기사외이사3인신규선임,http://www.newspim.com/news/view/20190827000795
499,2019-08-27,SK바이오팜전FDA부국장안해영박사등사외이사3인선임,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234269
500,2019-08-27,SK바이오팜사외이사에임상개발허가회계전문가3명선임,http://moneys.mt.co.kr/news/mwView.php?no=2019082715238038498
501,2019-08-27,상장추진SK바이오팜FDA출신등사외이사3인선임,http://www.newsis.com/view/?id=NISX20190827_0000752336&cID=13001&pID=13000
502,2019-08-27,SK바이오팜IPO속도낸다사외이사진개편,http://news.einfomax.co.kr/news/articleView.html?idxno=4045440
503,2019-08-27,SK바이오팜사외이사3인신규선임,http://medipana.com/news/news_viewer.asp?NewsNum=244651&MainKind=A&NewsKind=5&vCount=12&vKind=1
504,2019-08-27,IPO준비SK바이오팜방영주교수등사외인사3명신규선임,http://www.etoday.co.kr/news/section/newsview.php?idxno=1792339
505,2019-08-27,SK바이오팜IPO추진위해사외이사신규선임,http://www.fnnews.com/news/201908271542386330
506,2019-08-27,SK바이오팜안해영前FDA부국장등3인사외이사로선임,http://news.mt.co.kr/mtview.php?no=2019082715385840194
507,2019-08-27,SK바이오팜IPO앞두고사외이사신규선임투명성제고,https://view.asiae.co.kr/article/2019082715505316588
508,2019-08-27,SK바이오팜기업공개전이사회제도정비,http://yna.kr/AKR20190827126200017?did=1195m
509,2019-08-27,SK바이오팜사외이사3명신규선임이사회투명성제고,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201908270371&t=NN
510,2019-08-27,SK바이오팜전FDA부국장등3명사외이사선임,http://www.dailypharm.com/Users/News/NewsView.html?ID=256131&REFERER=NP
511,2019-08-27,SK바이오팜IPO추진앞두고의학약학경영학전문가사외이사영입,http://news.mk.co.kr/newsRead.php?year=2019&no=668606
512,2019-08-27,SK바이오팜사외이사3인신규선임상장요건맞는회사구축목표,http://www.sisafocus.co.kr/news/articleView.html?idxno=219276
513,2019-08-27,SK바이오팜새사외이사에방영주안해영송민섭씨,http://www.insightkorea.co.kr//news/articleView.html?idxno=54180
514,2019-08-27,기업공개추진SK바이오팜신규사외이사3명선임,http://news1.kr/articles/?3705223
515,2019-08-27,SK바이오팜사외이사3인선임IPO가속화,http://www.ajunews.com/view/20190827155823782
516,2019-08-27,SK바이오팜서울대종양내과출신방영주교수등사외이사선임,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019082716004058936
517,2019-08-27,SK바이오팜사외이사3인신규선임IPO가속화,http://www.seoulwire.com/news/articleView.html?idxno=205911
518,2019-08-27,SK바이오팜전FDA부국장등사외이사3명신규선임,http://www.econovill.com/news/articleView.html?idxno=370660
519,2019-08-27,SK바이오팜IPO증시동향美신약허가본뒤결정,http://news.heraldcorp.com/view.php?ud=20190827000774
520,2019-08-27,SK바이오팜IPO추진위해이사회정비,http://www.sisajournal-e.com/news/articleView.html?idxno=205262
521,2019-08-27,SK바이오팜IPO염두신규사외이사선임,https://www.nocutnews.co.kr/news/5204037
522,2019-08-27,서울대병원방영주교수SK바이오팜사외이사,http://www.medical-tribune.co.kr/news/articleView.html?idxno=87520
523,2019-08-27,IPO준비SK바이오팜사외이사3명신규선임,http://biz.newdaily.co.kr/site/data/html/2019/08/27/2019082700184.html
524,2019-08-27,SK바이오팜IPO앞두고방영주서울대병원교수등사외이사선임,http://biz.chosun.com/site/data/html_dir/2019/08/27/2019082702298.html
525,2019-08-27,SK바이오팜IPO공식화제약바이오업계부활할까,http://www.newsprime.co.kr/news/article.html?no=472996
526,2019-08-27,SK바이오팜사외이사신규선임기업공개전이사회제도정비,http://www.dt.co.kr/contents.html?article_no=2019082702109931102003&ref=naver
527,2019-08-27,SK바이오팜사외이사에방영주안해영송민섭기업공개준비작업,http://www.businesspost.co.kr/BP?command=article_view&num=141162
528,2019-08-27,SK바이오팜사외이사신규3인선임,https://www.kpanews.co.kr/article/show.asp?idx=206250&category=D
529,2019-08-27, SK바이오팜상장추진하며FDA출신등사외이사3인선임,http://www.techholic.co.kr/news/articleView.html?idxno=184936
530,2019-08-28,SK바이오팜사외이사3인신규선임美신약허가본뒤IPO결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=363396
531,2019-08-28,SK바이오팜사외이사3인신규선임,http://www.bosa.co.kr/news/articleView.html?idxno=2111341
532,2019-08-28,SK바이오팜IPO앞두고이사회제도정비투명성제고,http://www.seoulfn.com/news/articleView.html?idxno=353943
533,2019-08-28,SK바이오팜상장기대감저하로목표가↓특별배당은매력적한국,http://www.edaily.co.kr/news/newspath.asp?newsid=01439926622591912
534,2019-08-28,SKSK바이오팜상장기대감낮아져목표가↓한국투자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1792554
535,2019-08-28,SK바이오팜상장앞두고시장눈높이하향목표가↓,http://www.asiatoday.co.kr/view.php?key=20190828010015182
536,2019-08-28,SKSK바이오팜상장기대감낮아져목표가하향한국투자증권,http://www.fntimes.com/html/view.php?ud=2019082808533140066c0eb6f11e_18
537,2019-08-28,SK바이오팜사외이사3명선임방영주송민섭교수안해영박사,http://www.kukinews.com/news/article.html?no=695611
538,2019-08-28,SK목표주가하향자회사SK바이오팜상장하면주가상승가능,http://www.businesspost.co.kr/BP?command=article_view&num=141235
539,2019-08-28,리포트브리핑SKSK바이오팜과특별배당목표가325000원한국투자증권,http://www.newspim.com/news/view/20190828000447
540,2019-08-28,SK자회사SK바이오팜이사회는상장추진공식화”,http://www.wikitree.co.kr/main/news_view.php?id=458142
541,2019-08-30,바이오대어大魚SK바이오팜티움바이오상장시동,http://www.dailymedi.com/detail.php?number=846900&thread=22r05
542,2019-09-02,마켓파워사촌간닮은듯다른바이오의꿈SK바이오팜상장배경은,http://www.asiatoday.co.kr/view.php?key=20190901010000287
543,2019-09-02,글로벌시장직판노리는바이오SK바이오팜셀트리온성공여부관건,http://biz.newdaily.co.kr/site/data/html/2019/09/02/2019090200114.html
544,2019-09-03,더벨IPO추진SK바이오팜내부통제문제없나,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201908290100053520003306
545,2019-09-09,더벨SK바이오팜연내상장불투명빅딜부재올해도,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201909050100008820000553
546,2019-09-09,SK바이오팜유한양행독자개발신약단독글로벌임상,http://www.dt.co.kr/contents.html?article_no=2019091002101631102001&ref=naver
547,2019-09-18,더벨SK바이오팜IPO나스닥선회가능성솔솔,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201909160100023970001479
548,2019-10-18,상장추진SK바이오팜미국시장공략착착SK바이오사업중심축될까,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=534301
549,2019-10-18,SK바이오팜바이오시장서홈런치나美FDA허가기대에상장도추진,http://it.chosun.com/site/data/html_dir/2019/10/18/2019101801023.html
550,2019-10-20,뇌전증신약에사활건SK바이오팜美영업조직본격구축,http://www.newsis.com/view/?id=NISX20191018_0000803231&cID=13001&pID=13000
551,2019-10-21,미래에셋대우SKSK바이오팜지분가치부각기대매수,http://yna.kr/AKR20191021021800008?did=1195m
552,2019-10-21,SKSK바이오팜지분가치부각기대매수미래에셋대우,http://www.etoday.co.kr/news/section/newsview.php?idxno=1811575
553,2019-10-21,리포트브리핑SKSK바이오팜IPO에거는기대목표가300000원미래에셋대우,http://www.newspim.com/news/view/20191021000185
554,2019-10-21,미래에셋대우SK자회사SK바이오팜지분가치부각전망매수유지,http://www.seoulwire.com/news/articleView.html?idxno=238926
555,2019-10-21,투자종목미래에셋대우SKSK바이오팜IPO가주가상승견인할것,http://www.newswatch.kr/news/articleView.html?idxno=24492
556,2019-10-21,SK자회사SK바이오팜이주가상승견인할것,http://www.whitepaper.co.kr/news/articleView.html?idxno=177236
557,2019-10-21,미래에셋대우SK바이오팜상장으로기대감커진다,http://www.fetv.co.kr/news/article.html?no=38512
558,2019-10-21,미국신약허가앞둔SK바이오팜최태원바이오사랑빛보다,http://moneys.mt.co.kr/news/mwView.php?no=2019101809058011750
559,2019-10-21,SKSK바이오팜통해주가상승이끌것으로전망”,http://www.wikitree.co.kr/main/news_view.php?id=473656
560,2019-10-25,마켓인사이트5兆대어SK바이오팜IPO시동,https://www.hankyung.com/finance/article/2019102519491
561,2019-10-25,SK바이오팜코스피상장절차돌입,https://www.sedaily.com/NewsView/1VPNS8JBRR
562,2019-10-25,SK바이오팜유가증권시장상장추진예비심사신청서제출,http://www.fnnews.com/news/201910251817502218
563,2019-10-25,SK바이오팜코스피상장예비심사신청,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=004&oid=050&aid=0000051728
564,2019-10-25,SK바이오팜IPO시동예비심사신청서제출,http://www.upinews.kr/newsView/upi201910250093
565,2019-10-25,SK바이오팜한국거래소에코스피상장위한예비심사신청서제출,http://news.mk.co.kr/newsRead.php?year=2019&no=874307
566,2019-10-25,SK바이오팜IPO절차돌입,http://www.seoulfn.com/news/articleView.html?idxno=360391
567,2019-10-25,SK바이오팜상장예비심사신청서제출코스피입성초읽기,https://biz.chosun.com/site/data/html_dir/2019/10/25/2019102502216.html
568,2019-10-25,SK바이오팜유가증권시장상장본격추진,http://www.newsis.com/view/?id=NISX20191025_0000810513&cID=13001&pID=13000
569,2019-10-25,SK바이오팜코스피상장본격시동건다,http://www.newspim.com/news/view/20191025001171
570,2019-10-25,SK바이오팜코스피상장예비심사신청서제출IPO시동,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910250366&t=NN
571,2019-10-25,SK바이오팜코스피상장추진예비심사신청서제출,http://www.etoday.co.kr/news/section/newsview.php?idxno=1814240
572,2019-10-25,SK바이오팜유가증권시장상장본격추진예비심사신청서제출,http://www.newsway.co.kr/news/view?tp=1&ud=2019102518305605688
573,2019-10-25,바이오업계훈풍5兆예상SK바이오팜도IPO개시,http://news.mt.co.kr/mtview.php?no=2019102518403691668
574,2019-10-25,SK바이오팜유가증권시장상장예비심사신청,http://www.greened.kr/news/articleView.html?idxno=220163
575,2019-10-25,SK바이오팜코스피상장위해예비심사신청서제출,http://www.sisafocus.co.kr/news/articleView.html?idxno=224264
576,2019-10-25,SK바이오팜IPO시동코스피상장예비심사제출,http://www.seoulwire.com/news/articleView.html?idxno=242851
577,2019-10-25,시그널SK바이오팜유가증권IPO돌입이르면내년상장기대,https://www.sedaily.com/NewsView/1VPNRYVQQX
578,2019-10-25,SK바이오팜상장예비심사신청코스피상장본격추진,http://www.edaily.co.kr/news/newspath.asp?newsid=03585046622656528
579,2019-10-25,SK바이오팜코스피상장절차돌입예비심사신청서제출,http://www.viva100.com/main/view.php?key=20191025010008384
580,2019-10-25,SK바이오팜코스피상장본격추진예비심사신청서제출,http://biz.newdaily.co.kr/site/data/html/2019/10/25/2019102500177.html
581,2019-10-25,SK바이오팜예비심사신청서제출코스피상장본격추진,http://news.mt.co.kr/mtview.php?no=2019102518255250628
582,2019-10-25,대어SK바이오팜유가증권시장상장절차개시,https://www.sedaily.com/NewsView/1VPNT1OWPP
583,2019-10-25,SK바이오팜상장예비심사신청서접수,http://news.mk.co.kr/newsRead.php?year=2019&no=874536
584,2019-10-25,SK바이오팜거래소에코스피상장예비심사신청서제출,http://news1.kr/articles/?3753130
585,2019-10-25,SK바이오팜코스피상장예비심사신청서제출,http://www.shinailbo.co.kr/news/articleView.html?idxno=1217341
586,2019-10-25,SK그룹바이오기업SK바이오팜코스피상장추진,http://www.m-i.kr/news/articleView.html?idxno=649189
587,2019-10-25,SK그룹바이오기업SK바이오팜코스피상장추진,http://www.kukinews.com/news/article.html?no=713361
588,2019-10-25,SK바이오팜코스피시장상장본격추진‥예비심사신청서제출,http://medipana.com/news/news_viewer.asp?NewsNum=247597&MainKind=A&NewsKind=5&vCount=12&vKind=1
589,2019-10-25,SK바이오팜코스피상장본격추진예비심사신청서제출,http://www.mdtoday.co.kr/mdtoday/index.html?no=368499
590,2019-10-26,SK바이오팜예비심사신청서제출유가증권시장상장본격추진,https://view.asiae.co.kr/article/2019102606385748149
591,2019-10-26,SK바이오팜유가증권시장상장예비심사신청서제출,http://www.ebn.co.kr/news/view/1006463/?sc=naver
592,2019-10-26,신약개발바이오기업SK바이오팜IPO추진코스피상장절차개시,http://kpenews.com/View.aspx?No=301723
593,2019-10-27,SK바이오팜코스닥상장예비심사청구,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236570
594,2019-10-27,SK바이오팜유가증권상장위해예비심사신청서제출,http://asiatime.co.kr/news/newsview.php?ncode=1065605299076113
595,2019-10-27,상장전신약개발판매까지한SK바이오팜IPO돌입,http://news.heraldcorp.com/view.php?ud=20191027000051
596,2019-10-27,SK바이오팜예비심사신청서제출,http://www.ajunews.com/view/20191027095545764
597,2019-10-27,SK바이오팜코스피예비심사청구,http://www.finomy.com/news/articleView.html?idxno=70916
598,2019-10-28,HotLineSKSK바이오팜상장은할인율축소계기,http://news.mk.co.kr/newsRead.php?year=2019&no=879058
599,2019-10-28,SK주가상승가능자회사SK바이오팜상장으로기업가치커져,http://www.businesspost.co.kr/BP?command=article_view&num=148609
600,2019-10-28,더벨SK바이오팜IPO출사표이익미실현기준충족,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201910250100048520003022
601,2019-10-28,SK자회사SK바이오팜내년초상장예상,http://www.nspna.com/news/?mode=view&newsid=390051
602,2019-10-28,IB토마토SK바이오팜예비심사신청서제출IPO본격화,http://www.newstomato.com/ReadNews.aspx?no=929103
603,2019-10-28,특징주SKSK바이오팜상장할인율축소계기목표주가23만5천원매수의견유지,http://www.shinailbo.co.kr/news/articleView.html?idxno=1217746
604,2019-10-28,SK바이오팜유가증권시장상장본격추진예비심사신청서제출,http://www.rpm9.com/news/article.html?id=20191028090020
605,2019-10-28,SK바이오팜상장위해예비심사신청서제출,http://www.whosaeng.com/113546
606,2019-10-28,SK바이오팜코스피예비심사신청,https://www.nocutnews.co.kr/news/5234259
607,2019-10-28,리포트브리핑SKSK바이오팜상장할인율축소계기목표가325000원한국투자증권,http://www.newspim.com/news/view/20191028000767
608,2019-10-28,특별배당들어봤니SK바이오팜상장으로투자형지주사본색,https://www.hankyung.com/finance/article/2019102862486
609,2019-10-28,시총5조대어SK바이오팜의성공교훈3가지,http://news.mt.co.kr/mtview.php?no=2019102814201700859
610,2019-10-28,SK주가상승SK바이오팜상장되면배당확대기대높아져,http://www.businesspost.co.kr/BP?command=article_view&num=148726
611,2019-10-29,SK바이오팜상장시동닻올린최태원표바이오산업,http://www.ajunews.com/view/20191028154726674
612,2019-10-29,더벨SK바이오팜IPO스타트세가지키워드는,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201910280100050750003158
613,2019-10-29,5兆대어SK바이오팜뇌전증신약신성장동력되나,http://fn.segye.com/content/html/2019/10/29/20191029510346.html?OutUrl=naver
614,2019-10-30,더벨SK바이오팜11년전실패후재기성공비결주목,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201910290100054420003378
615,2019-10-30,내년IPOSK바이오팜26년RD저력보여줄까,http://www.econovill.com/news/articleView.html?idxno=376024
616,2019-10-30,SK바이오팜기업가치5조에서10조하늘과땅뇌전증신약이좌우,http://www.businesspost.co.kr/BP?command=article_view&num=149033
617,2019-11-04,SK바이오팜상장한다,http://weekly.hankooki.com/lpage/economy/201911/wk20191104080050146390.htm
618,2019-11-04,더벨SK바이오팜IPO그룹컨트롤막전막후,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201911010100001980000130
619,2019-11-07,SK바이오팜신약개발실패악몽딛고코스피상장노크fn종목돋보기,http://www.fnnews.com/news/201911071822594421
620,2019-11-09,SK바이오팜등바이오기업내년IPO봇물예상,http://www.choicenews.co.kr/news/articleView.html?idxno=65596
621,2019-11-11,더벨SK바이오팜IPOSK지배구조재편키,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201911050100007040000435
622,2019-11-11,더벨SK바이오팜IPO승인세노바메이트허가관건,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201911050100007840000477
623,2019-11-13,움츠렸던바이오株IPO연말연초기지개켜나SK바이오팜주목,http://biz.newdaily.co.kr/site/data/html/2019/11/13/2019111300165.html
624,2019-11-13,SK바이오팜일등공신장동현대표연임기대감솔솔,http://www.newsway.co.kr/news/view?tp=1&ud=2019111316274988029
625,2019-11-15,SK주가오를힘충분자회사들실적좋고SK바이오팜도상장앞둬,http://www.businesspost.co.kr/BP?command=article_view&num=151265
626,2019-11-15,SK바이오팜뇌전증신약임상란셋뉴롤로지게재,http://moneys.mt.co.kr/news/mwView.php?no=2019111509348084026
627,2019-11-15,SK바이오팜세노바메이트주요임상결과세계적학술지란셋뉴롤로지게재,https://www.sedaily.com/NewsView/1VQT31JTRP
628,2019-11-15,SK바이오팜세노바메이트임상결과란셋뉴롤로지게재,http://medipana.com/news/news_viewer.asp?NewsNum=248679&MainKind=A&NewsKind=5&vCount=12&vKind=1
629,2019-11-15,SK바이오팜세노바메이트임상결과학술지게재,http://www.sisafocus.co.kr/news/articleView.html?idxno=225800
630,2019-11-15,SK바이오팜뇌전증신약FDA허가앞두고란셋에게재,http://www.seoulwire.com/news/articleView.html?idxno=254358
631,2019-11-15,SK바이오팜뇌전증치료제신약임상결과학술지게재,http://www.newspim.com/news/view/20191115000584
632,2019-11-15,SK바이오팜세노바메이트임상결과세계적학술지게재,http://biz.newdaily.co.kr/site/data/html/2019/11/15/2019111500030.html
633,2019-11-15,SK바이오팜뇌전증신약발작감소대폭개선논문개제,http://news.mt.co.kr/mtview.php?no=2019111510122648190
634,2019-11-15,SK바이오팜세노바메이트임상결과란셋뉴롤로지게재,http://www.ebn.co.kr/news/view/1009427/?sc=naver
635,2019-11-15,SK바이오팜세노바메이트임상결과란셋게재,http://www.bosa.co.kr/news/articleView.html?idxno=2116084
636,2019-11-15,SK바이오팜세노바메이트임상결과국제학술지게재,http://www.etnews.com/20191115000104
637,2019-11-15,SK바이오팜세노바메이트주요임상결과랜싯뉴롤로지게재,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=237459
638,2019-11-15,SK바이오팜뇌전증신약임상서발작빈도감소확인,http://yna.kr/AKR20191115063600017?did=1195m
639,2019-11-15,SK바이오팜세노바메이트주요임상결과세계적학술지란셋뉴롤로지에게재,http://sports.khan.co.kr/news/sk_index.html?art_id=201911151107003&sec_id=561801&pt=nv
640,2019-11-15,SK바이오팜뇌전증약세노바메이트임상시험결과발표,http://www.medical-tribune.co.kr/news/articleView.html?idxno=88971
641,2019-11-15,SK바이오팜뇌전증치료신약발작감소효과확인,http://www.shinailbo.co.kr/news/articleView.html?idxno=1223986
642,2019-11-15,SK바이오팜세노바메이트유력학술지란셋뉴롤로지게재,http://www.newsis.com/view/?id=NISX20191115_0000830974&cID=13001&pID=13000
643,2019-11-15,SK바이오팜뇌전증치료제세노바메이트임상결과란셋뉴롤로지게재,https://biz.chosun.com/site/data/html_dir/2019/11/15/2019111501750.html?utm_source=naver&utm_medium=original&utm_campaign=biz
644,2019-11-15,SK바이오팜뇌전증신약개발순항,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1074221
645,2019-11-15,SK바이오팜세노바메이트복용군발작빈도줄었다국제학술지게제,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201911150223&t=NN
646,2019-11-15,SK바이오팜세노바메이트임상서발작빈도감소확인,http://www.seoulfn.com/news/articleView.html?idxno=362638
647,2019-11-15,SK바이오팜세노바메이트임상결과란셋에게재”,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=004&oid=050&aid=0000051896
648,2019-11-15,SK바이오팜세노바메이트임상결과란셋뉴롤로지에게재,http://www.fnnews.com/news/201911151434225946
649,2019-11-15,SK바이오팜세노바메이트발작빈도감소효과확인,https://view.asiae.co.kr/article/2019111514373189247
650,2019-11-15,SK바이오팜세노바메이트임상결과세계적학술지에게재,http://www.ekn.kr/news/article.html?no=464087
651,2019-11-15,SK바이오팜세노바메이트임상결과권위학술지란셋게재,http://kormedi.com/?p=1305865
652,2019-11-15,SK바이오팜세노바메이트임상결과란셋뉴롤로지에게재,http://www.newsway.co.kr/news/view?tp=1&ud=2019111515003303869
653,2019-11-15,SK바이오팜뇌전증치료제효과국제학술지란셋뉴롤로지게재,http://www.metroseoul.co.kr/news/newsview?newscd=2019111500076
654,2019-11-15,SK바이오팜뇌전증신약임상서발작빈도감소확인,https://jhealthmedia.joins.com/article/article_view.asp?pno=21099
655,2019-11-15,SK바이오팜세노바메이트주요임상결과세계적학술지게재,http://www.newstomato.com/ReadNews.aspx?no=933711
656,2019-11-15,SK바이오팜세노바메이트뇌전증환자서발작빈도감소”,http://www.viva100.com/main/view.php?key=20191115010005366
657,2019-11-15,SK바이오팜뇌전증신약의임상결과를세계적학술지에게재,http://www.businesspost.co.kr/BP?command=article_view&num=151387
658,2019-11-15,SK바이오팜세노바메이트임상결과란셋뉴롤로지에게재,http://www.paxetv.com/news/articleView.html?idxno=81663
659,2019-11-15,뉴스투데이LSK바이오팜세노바메이트세계적학술지에임상결과게재,http://www.news2day.co.kr/142102
660,2019-11-15,SK바이오팜세노바메이트임상결과해외학술지에게재,http://www.ajunews.com/view/20191115222929264
661,2019-11-16,SK바이오팜세노바메이트임상결과란셋뉴롤로지에게재돼,https://www.kpanews.co.kr/article/show.asp?idx=208591&category=D
662,2019-11-17,유럽CHMPSK바이오팜솔리암페톨판매승인권고,http://www.viva100.com/main/view.php?key=20191117010005603
663,2019-11-17,SK바이오팜수면장애신약유럽CHMP판매승인권고,https://biz.chosun.com/site/data/html_dir/2019/11/17/2019111700138.html?utm_source=naver&utm_medium=original&utm_campaign=biz
664,2019-11-17,SK바이오팜수면장애신약유럽CHMP판매승인권고,http://yna.kr/AKR20191117009500017?did=1195m
665,2019-11-17,SK바이오팜수면장애신약유럽CHMP판매승인권고,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019111709092633935
666,2019-11-17,SK바이오팜기술수출한솔리암페톨유럽허가눈앞,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=004&oid=050&aid=0000051897
667,2019-11-17,SK바이오팜솔리암페톨이르면내년1월유럽판매허가,http://news.mt.co.kr/mtview.php?no=2019111709252332104
668,2019-11-17,SK바이오팜수면장애신약유럽CHMP판매승인권고,http://www.seoulwire.com/news/articleView.html?idxno=255154
669,2019-11-17,유럽CHMPSK바이오팜수면장애신약판매승인권고,http://it.chosun.com/site/data/html_dir/2019/11/17/2019111700167.html
670,2019-11-17,SK바이오팜수면장애신약솔리암페톨유럽CHMP판매승인권고,http://www.etoday.co.kr/news/section/newsview.php?idxno=1823064
671,2019-11-17,SK바이오팜의수면장애신약유럽약물사용자문위원회서승인권고받아내,http://news.mk.co.kr/newsRead.php?year=2019&no=952699
672,2019-11-17,SK바이오팜수면장애신약유럽CHMP판매승인권고,http://www.biospectator.com/view/news_view.php?varAtcId=8913
673,2019-11-17,SK바이오팜수면장애신약유럽판매허가임박,http://news.einfomax.co.kr/news/articleView.html?idxno=4057201
674,2019-11-17,SK바이오팜수면장애신약유럽CHMP판매승인권고,http://www.newsis.com/view/?id=NISX20191117_0000832005&cID=13001&pID=13000
675,2019-11-17,SK바이오팜솔리암페톨유럽CHMP판매승인권고,http://medipana.com/news/news_viewer.asp?NewsNum=248717&MainKind=A&NewsKind=5&vCount=12&vKind=1
676,2019-11-17,SK바이오팜솔리암페톨미국이어유럽공략나선다,http://www.newspim.com/news/view/20191117000018
677,2019-11-17,SK바이오팜뇌전증치료제효과국제학술지란셋뉴롤로지게재,http://www.metroseoul.co.kr/news/newsview?newscd=2019111500075
678,2019-11-17,SK바이오팜수면장애신약유럽CHMP판매승인권고,http://www.ekn.kr/news/article.html?no=464345
679,2019-11-17,SK바이오팜수면장애신약유럽CHMP판매승인권고,http://www.mdtoday.co.kr/mdtoday/index.html?no=370382
680,2019-11-17,SK바이오팜수면장애신약유럽CHMP판매승인권고,http://www.fnnews.com/news/201911171236229812
681,2019-11-17,SK바이오팜솔리암페톨유럽CHMP판매승인권고,http://www.sisafocus.co.kr/news/articleView.html?idxno=225924
682,2019-11-17,SK바이오팜수면장애신약유럽판매승인권고,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201911170019&t=NN
683,2019-11-17,SK바이오팜수면장애신약유럽CHMP판매승인권고,http://news.heraldcorp.com/view.php?ud=20191117000143
684,2019-11-17,SK바이오팜수면장애신약유럽CHMP판매승인권고,http://www.etnews.com/20191117000049
685,2019-11-17,SK바이오팜수면장애신약솔리암페톨유럽CHMP판매승인권고”,http://www.newsway.co.kr/news/view?tp=1&ud=2019111714405720228
686,2019-11-17,SK바이오팜수면장애신약유럽CHMP판매승인권고,http://www.dt.co.kr/contents.html?article_no=2019111702109931102002&ref=naver
687,2019-11-17,SK바이오팜자체개발신약으로美공략하는첫토종제약사의탄생,http://www.metroseoul.co.kr/news/newsview?newscd=2019111700088
688,2019-11-17,SK바이오팜수면장애신약솔리암페톨유럽판매승인권고,http://daily.hankooki.com/lpage/industry/201911/dh20191117155853147950.htm
689,2019-11-17,SK바이오팜수면장애신약유럽CHMP판매승인권고,https://www.hankyung.com/it/article/2019111731501
690,2019-11-17,SK바이오팜수면장애신약美이어유럽출시눈앞,https://www.sedaily.com/NewsView/1VQU0TOU53
691,2019-11-17,SK바이오팜수면장애신약솔리암페톨美진출이어유럽판매임박,http://www.fnnews.com/news/201911171749043680
692,2019-11-17,SK바이오팜수면장애신약유럽CHMP판매승인권고,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=237477
693,2019-11-17,SK바이오팜뇌전증치료신약세노바메이트유력학술지란셋뉴롤로지게재,http://www.econonews.co.kr/news/articleView.html?idxno=94920
694,2019-11-17,SK바이오팜솔리암페톨유럽판매초읽기글로벌상업화전략착수,http://www.paxetv.com/news/articleView.html?idxno=81710
695,2019-11-18,SK바이오팜수면장애신약유럽판매청신호,http://www.donga.com/news/article/all/20191117/98410268/1
696,2019-11-18,SK바이오팜FDA허가가능성↑제약바이오주냉각심리녹일재료”미래에셋대우,http://www.fntimes.com/html/view.php?ud=201911180827048123f09e13944d_18
697,2019-11-18,SKAI신약개발사투자SK바이오팜과시너지기대”,http://daily.hankooki.com/lpage/industry/201911/dh20191118104605147950.htm
698,2019-11-18,뉴스락주식네비11월18일SK바이오팜세노바메이트성공가능성높아져FDA허가가능할전망,http://www.newslock.co.kr/news/articleView.html?idxno=23428
699,2019-11-18,SK바이오팜수면장애신약솔리암페톨유럽판매승인임박,http://www.econovill.com/news/articleView.html?idxno=377726
700,2019-11-18,SK바이오팜수면장애신약유럽CHMP판매승인권고,http://www.bosa.co.kr/news/articleView.html?idxno=2116176
701,2019-11-18,SK바이오팜수면장애신약미국이어유럽진출초읽기,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1074261
702,2019-11-18,SKAI신약개발기업스탠다임투자SK바이오팜시너지기대,http://www.ceoscoredaily.com/news/article.html?no=62607
703,2019-11-18,SK바이오팜솔리암페톨유럽판매승인권고얻어,https://www.nocutnews.co.kr/news/5245314
704,2019-11-18,SK바이오팜수면장애신약유럽서판매승인권고받아,http://www.munhwa.com/news/view.html?no=2019111801032327107001
705,2019-11-18,SKAI신약개발사에100억투자SK바이오팜과시너지기대”,http://www.fetv.co.kr/news/article.html?no=40672
706,2019-11-19,SK바이오팜수면장애신약유럽CHMP판매승인권고,http://news.heraldcorp.com/view.php?ud=20191119000164
707,2019-11-19,SKAI신약개발사스탠다임에100억투자자회사SK바이오팜기술개발에일조할듯,http://www.kdpress.co.kr/news/articleView.html?idxno=93516
708,2019-11-20,더벨SK㈜AI신약업체투자로SK바이오팜후방지원,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201911190100035160002171
709,2019-11-20,SK바이오팜수면장애신약유럽서판매승인권고,http://news.heraldcorp.com/view.php?ud=20191120000411
710,2019-11-21,최태원회장야심작SK바이오팜제약바이오산업구원투수되나,http://it.chosun.com/site/data/html_dir/2019/11/21/2019112100907.html
711,2019-11-21,IB토마토IPO인사이트SK바이오팜IPO완주세노바메이트에달렸다,http://www.newstomato.com/ReadNews.aspx?no=935050
712,2019-11-22,화제의키워드화웨이메이트X화면수리비용방탄소년단병역혜택제외SK바이오팜,http://it.chosun.com/site/data/html_dir/2019/11/21/2019112102691.html
713,2019-11-22,SK바이오팜독자개발뇌전증신약美FDA승인상보,https://view.asiae.co.kr/article/2019112117210135856
714,2019-11-22,SK바이오팜독자개발뇌전증신약미국FDA허가,http://yna.kr/AKR20191122017900017?did=1195m
715,2019-11-22,SK바이오팜뇌전증혁신신약전과정독자개발로美FDA승인,http://news.heraldcorp.com/view.php?ud=20191122000011
716,2019-11-22,SK바이오팜미FDA서뇌전증신약시판허가1보,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201911220032&t=NN
717,2019-11-22,SK바이오팜뇌전증신약최초독자개발美FDA승인속보,http://www.edaily.co.kr/news/newspath.asp?newsid=01403846622688344
718,2019-11-22,SK바이오팜세노바메이트美FDA승인,https://www.sedaily.com/NewsView/1VQWAV2LY8
719,2019-11-22,SK바이오팜국내최초독자개발엑스코프리美FDA허가,http://www.viva100.com/main/view.php?key=20191122010007613
720,2019-11-22,SK바이오팜성인발작신약미국FDA품목허가1보,http://news1.kr/articles/?3775381
721,2019-11-22,SK바이오팜뇌전증신약대한민국최초독자개발美FDA승인,http://www.newspim.com/news/view/20191122000045
722,2019-11-22,최태원의바이오뚝심통했다SK바이오팜국내첫독자개발신약결실,https://www.hankyung.com/finance/article/2019112249826
723,2019-11-22,SK바이오팜뇌전증신약엑스코프리美FDA허가,http://www.getnews.co.kr/view.php?ud=201911220745005756fab1982f6a_16
724,2019-11-22,SK바이오팜독자개발뇌전증신약미국FDA승인,http://www.dailypharm.com/Users/News/NewsView.html?ID=259210&REFERER=NP
725,2019-11-22,SK바이오팜뇌전증신약엑스코프리FDA허가,http://www.biospectator.com/view/news_view.php?varAtcId=8953
726,2019-11-22,SK바이오팜독자개발뇌전증신약美FDA승인상보,http://www.edaily.co.kr/news/newspath.asp?newsid=01436646622688344
727,2019-11-22,최태원의뚝심SK바이오팜美서혁신신약시판허가,http://www.ajunews.com/view/20191122080204372
728,2019-11-22,美문턱홀로넘었다SK바이오팜독자개발뇌전증신약FDA승인종합,https://view.asiae.co.kr/article/2019112208085383192
729,2019-11-22,SK바이오팜독자개발뇌전증신약미국FDA허가종합,http://yna.kr/AKR20191122017951017?did=1195m
730,2019-11-22,SK바이오팜뇌전증신약대한민국최초독자개발로美FDA승인,http://www.newsway.co.kr/news/view?tp=1&ud=2019112207512757147
731,2019-11-22,SK바이오팜뇌전증치료제美판매승인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=89088
732,2019-11-22,최태원뚝심결실SK바이오팜뇌전증신약엑스코프리FDA승인,http://www.newsfreezone.co.kr/news/articleView.html?idxno=207304
733,2019-11-22,SK바이오팜뇌전증혁신신약엑스코프리美FDA승인,http://www.econovill.com/news/articleView.html?idxno=378161
734,2019-11-22,SK바이오팜뇌전증신약미국판매허가얻어조정우글로벌도약,http://www.businesspost.co.kr/BP?command=article_view&num=152191
735,2019-11-22,SK바이오팜뇌전증신약한국최초독자개발로美FDA승인,http://medipana.com/news/news_viewer.asp?NewsNum=249041&MainKind=A&NewsKind=5&vCount=12&vKind=1
736,2019-11-22,SK바이오팜독자개발뇌전증신약미국FDA허가,http://www.asiatoday.co.kr/view.php?key=20191122010012970
737,2019-11-22,SK바이오팜뇌전증혁신신약독자개발로美FDA승인,http://www.fnnews.com/news/201911220828218101
738,2019-11-22,주가에호재이미반영vs다시상승세탈것SK바이오팜뇌전증혁신신약허가SK주가주목,http://www.g-enews.com/ko-kr/news/article/news_all/2019112208260726634e4869c120_1/article.html
739,2019-11-22,SK바이오팜뇌전증신약美FDA시판허가,http://www.kukinews.com/news/article.html?no=721464
740,2019-11-22,SK바이오팜독자개발뇌전증신약美FDA시판허가종합,http://www.edaily.co.kr/news/newspath.asp?newsid=01603926622688344
741,2019-11-22,SK바이오팜뇌전증치료제美FDA승인최태원뚝심통했다,http://news.mt.co.kr/mtview.php?no=2019112208094908406
742,2019-11-22,SK바이오팜뇌전증치료제美FDA승인최태원뚝심통했다,http://news.mt.co.kr/mtview.php?no=2019112208094908406
743,2019-11-22,최태원회장신약투자첫결실SK바이오팜뇌전증신약FDA허가,http://moneys.mt.co.kr/news/mwView.php?no=2019112208258046350
744,2019-11-22,SK바이오팜뇌전증신약미국FDA승인K바이오저력,http://www.newsis.com/view/?id=NISX20191122_0000837789&cID=13001&pID=13000
745,2019-11-22,최태원뚝심결실SK바이오팜독자개발뇌전증신약FDA허가,http://www.youthdaily.co.kr/news/article.html?no=23192
746,2019-11-22,SK바이오팜美FDA뇌전증신약엑스코프리시판허가,http://news.mk.co.kr/newsRead.php?year=2019&no=971931
747,2019-11-22,SK바이오팜중추신경계신약세계시장장악꿈가시권,http://news.heraldcorp.com/view.php?ud=20191122000041
748,2019-11-22,SK바이오팜뇌전증혁신신약美FDA승인한국최초독자개발,http://www.dt.co.kr/contents.html?article_no=2019112202109931102001&ref=naver
749,2019-11-22,SK바이오팜뇌전증혁신신약엑스코프리FDA승인획득,http://www.newstomato.com/ReadNews.aspx?no=935141
750,2019-11-22,공시SKSK바이오팜미국FDA서뇌전증신약판매승인”,http://www.newsway.co.kr/news/view?tp=1&ud=2019112208433707995
751,2019-11-22,SK바이오팜뇌전증신약미FDA승인33억달러시장노크한다,http://news.tf.co.kr/read/economy/1769089.htm
752,2019-11-22,최태원뚝심경영통했다SK바이오팜뇌전증치료제엑스코프리FDA승인,http://www.metroseoul.co.kr/news/newsview?newscd=2019112200008
753,2019-11-22,SK바이오팜뇌전증혁신신약美FDA승인,http://news.mt.co.kr/mtview.php?no=2019112208390876471
754,2019-11-22,최태원회장의27년뚝심SK바이오팜신약결실,http://www.fnnews.com/news/201911220853442312
755,2019-11-22,SK최태원뚝심SK바이오팜뇌전증치료제엑스코프리신약승인,http://www.consumuch.com/news/articleView.html?idxno=46648
756,2019-11-22,최태원의뚝심SK바이오팜뇌전증신약美FDA승인,http://www.shinailbo.co.kr/news/articleView.html?idxno=1226166
757,2019-11-22,SK바이오팜뇌전증신약美허가독자개발첫성과,http://biz.newdaily.co.kr/site/data/html/2019/11/22/2019112200017.html
758,2019-11-22,SK바이오팜뇌전증혁신신약독자개발로미국FDA승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=237709
759,2019-11-22,SK바이오팜독자개발뇌전증신약美FDA허가2020년출시예정,http://sports.chosun.com/news/ntype.htm?id=201911230100185170012452&servicedate=20191122
760,2019-11-22,SK바이오팜뇌전증신약엑스코프리성분명세노바메이트미국식품의약국FDA승인발작치료제시판허가,http://www.econonews.co.kr/news/articleView.html?idxno=95479
761,2019-11-22,SK바이오팜뇌전증치료신약엑스코프리美FDA승인,http://www.kukinews.com/news/article.html?no=721471
762,2019-11-22,SK바이오팜뇌전증혁신신약美FDA승인국내독자개발최초성과,http://www.sportsseoul.com/news/read/852230
763,2019-11-22,최태원의27년뚝심SK바이오팜독자개발뇌전증신약美FDA승인,http://www.inews24.com/view/1224122
764,2019-11-22,SK바이오팜뇌전증신약美FDA판매승인,http://www.edaily.co.kr/news/newspath.asp?newsid=01790886622688344
765,2019-11-22,SKSK바이오팜뇌전증신약FDA판매승인,http://www.etoday.co.kr/news/section/newsview.php?idxno=1825409
766,2019-11-22,최태원회장의27년뚝심SK바이오팜신약결실,http://yna.kr/PYH20191122021400013?did=1196m
767,2019-11-22,SK바이오팜독자개발뇌전증신약美FDA시판허가,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201911220045&t=NN
768,2019-11-22,SK바이오팜뇌전증혁신신약엑스코프리美FDA시판허가,http://www.kukinews.com/news/article.html?no=721478
769,2019-11-22,SK바이오팜독자개발뇌전증신약미국FDA허가,http://yna.kr/PYH20191122012400017?did=1196m
770,2019-11-22,SK바이오팜뇌전증혁신신약美FDA승인,http://www.bosa.co.kr/news/articleView.html?idxno=2116514
771,2019-11-22,SK바이오팜美FDA서독자개발뇌전증신약품목허가받았다,http://www.opinionnews.co.kr/news/articleView.html?idxno=25970
772,2019-11-22,SK바이오팜화제오른이유는,http://www.ccreview.co.kr/news/articleView.html?idxno=218459
773,2019-11-22,최태원27년바이오뚝심결실SK바이오팜뇌전증신약미FDA허가,http://www.paxetv.com/news/articleView.html?idxno=82032
774,2019-11-22,SK바이오팜뇌전증신약엑스코프리미국FDA허가,http://www.cstimes.com/?mod=news&act=articleView&idxno=321395
775,2019-11-22,SK바이오팜독자개발뇌전증혁신신약美FDA승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=370843
776,2019-11-22,美FDA승인받은SK바이오팜뇌전증신약출시예상시점은,http://www.etoday.co.kr/news/section/newsview.php?idxno=1825402
777,2019-11-22,sk바이오팜성인발작치료제출시되나,http://www.anewsa.com/detail.php?number=2021512&thread=10r02
778,2019-11-22,최태원회장27년바이오뚝심SK바이오팜독자신약결실,http://www.edaily.co.kr/news/newspath.asp?newsid=01879446622688344
779,2019-11-22,SK바이오팜독자개발뇌전증혁신신약미국FDA승인,http://www.etoday.co.kr/news/section/newsview.php?idxno=1825399
780,2019-11-22,SK바이오팜뇌전증신약美FDA허가최태원뚝심결실,http://www.sentv.co.kr/news/view/564405
781,2019-11-22,SK바이오팜독자개발뇌전증신약미국FDA시판허가,http://health.chosun.com/site/data/html_dir/2019/11/22/2019112201049.html
782,2019-11-22,SK바이오팜뇌전증혁신신약엑스코프리美FDA승인,http://www.segye.com/content/html/2019/11/22/20191122503285.html?OutUrl=naver
783,2019-11-22,SK바이오팜독자개발뇌전증신약美FDA시판허가,https://www.nocutnews.co.kr/news/5247725
784,2019-11-22,SK바이오팜독자신약美FDA허가획득,http://www.etnews.com/20191122000050
785,2019-11-22,최태원회장27년바이오뚝심SK바이오팜국내첫독자개발신약으로결실,http://www.getnews.co.kr/view.php?ud=2019112209365741356a6b374224_16
786,2019-11-22,SK자회사SK바이오팜자체개발뇌전증약FDA허가획득,https://www.ajunews.com/view/20191122090537459
787,2019-11-22,SK바이오팜독자개발뇌전증신약미국FDA승인,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003788052
788,2019-11-22,최태원27년뚝심SK바이오팜뇌전증신약美FDA승인,http://www.newspost.kr/news/articleView.html?idxno=73922
789,2019-11-22,혁신신약외길성공SK바이오팜FDA승인끌어내,http://www.mhj21.com/125842
790,2019-11-22,SK바이오팜뇌전증신약엑스코프리美허가발작감소,http://www.medisobizanews.com/news/articleView.html?idxno=64189
791,2019-11-22,SK바이오팜독자개발신약FDA승인최태원회장27년바이오뚝심결실,http://www.enewstoday.co.kr/news/articleView.html?idxno=1350976
792,2019-11-22,특징주SK바이오랜드SK바이오팜신약허가에급등,http://www.enewstoday.co.kr/news/articleView.html?idxno=1350991
793,2019-11-22,SK바이오팜국내첫독자개발뇌전증신약美FDA승인낭보,http://www.koreastocknews.com/news/articleView.html?idxno=48250
794,2019-11-22,SK바이오팜뇌전증신약미국FDA허가,https://www.ytn.co.kr/_ln/0103_201911221008130322
795,2019-11-22,SK바이오팜독자개발뇌전증신약미국FDA허가,https://cnbc.sbs.co.kr/article_hub/10000963263?division=NAVER
796,2019-11-22,SK바이오팜뇌전증국내첫신약개발FDA승인,http://www.beyondpost.co.kr/view.php?ud=201911221006315377c5c1bde209_30
797,2019-11-22,최소5조원몸값SK바이오팜상장가속도특별배당SK밸류개선기대감,http://news.heraldcorp.com/view.php?ud=20191122000170
798,2019-11-22,SK바이오팜독자개발뇌전증신약미국FDA허가,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3991411
799,2019-11-22,SK바이오팜뇌전증신약FDA승인에최태원회장뚝심결실,https://www.ytn.co.kr/_ln/0102_201911221016219472
800,2019-11-22,SK바이오팜덕분SK바이오랜드장중주가급등,http://www.choicenews.co.kr/news/articleView.html?idxno=65932
801,2019-11-22,최태원회장27년바이오뚝심SK바이오팜첫독자개발신약결실,http://www.topdaily.kr/news/articleView.html?idxno=61187
802,2019-11-22,SK바이오팜美FDA시판허가로국내첫신약결실최태원의바이오뚝심통해,http://www.sportsseoul.com/news/read/852258
803,2019-11-22,단독개발FDA신약1호SK바이오팜엑스코프리난치성뇌전증에희망,http://www.newspim.com/news/view/20191122000195
804,2019-11-22,SK바이오팜뇌전증신약독자개발美FDA승인최태원회장뚝심결실,http://www.newslock.co.kr/news/articleView.html?idxno=23600
805,2019-11-22,최태원회장바이오뚝심결실SK바이오팜신약美FDA승인,http://www.asiatoday.co.kr/view.php?key=20191122010013073
806,2019-11-22,SK바이오팜뇌전증혁신신약美FDA승인최초독자개발 ,http://www.sisafocus.co.kr/news/articleView.html?idxno=226285
807,2019-11-22,SK최태원오너경영장점살려SK바이오팜투자결실맺었다,http://www.sisajournal-e.com/news/articleView.html?idxno=209395
808,2019-11-22,SK바이오랜드SK바이오팜신약미FDA허가소식에급등,https://www.hankyung.com/finance/article/2019112256866
809,2019-11-22,리포트브리핑SKSK바이오팜뇌전증신약미국판매허가획득BUYKB증권,http://www.newspim.com/news/view/20191122000348
810,2019-11-22,최태원회장바이오뚝심통했다SK바이오팜세노바메이트美FDA시판허가,http://it.chosun.com/site/data/html_dir/2019/11/22/2019112201369.html
811,2019-11-22,최태원회장바이오의지결실SK바이오팜신약美FDA허가,http://www.donga.com/news/article/all/20191122/98487215/2
812,2019-11-22,SK바이오팜세노바메이트美FDA허가독자개발신약으로는최초,http://www.g-enews.com/ko-kr/news/article/news_all/2019112210241184969d76442fa_1/article.html
813,2019-11-22,SK바이오팜의뇌전증치료제엑스코프리美FDA승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58319
814,2019-11-22,SK바이오팜뇌전증신약엑스코프리개발에서허가까지,http://www.fnnews.com/news/201911221005414234
815,2019-11-22,한민수의스톡뷰SK바이오팜IPO성공예약母회사도눈여겨봐야,https://www.hankyung.com/finance/article/2019112256456
816,2019-11-22,SK바이오팜뇌전증신약엑스코프리미국FDA허가,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0300&key=20191122.99099009888
817,2019-11-22,최태원회장의뚝심SK바이오팜독자개발뇌전증신약미국FDA허가,http://fn.segye.com/content/html/2019/11/22/20191122505120.html?OutUrl=naver
818,2019-11-22,SK바이오팜뇌전증신약美FDA판매허가,http://news.kmib.co.kr/article/view.asp?arcid=0013957130&code=61121911&cp=nv
819,2019-11-22,SK바이오팜독자개발뇌전증신약세노바메이트美FDA승인,http://www.betanews.net:8080/article/1104278.html
820,2019-11-22,SK바이오팜뇌전증신약국내최초독자개발로미국FDA승인,http://kormedi.com/?p=1306260
821,2019-11-22,SK바이오랜드갑작스런상한가SK바이오팜효과,http://www.econonews.co.kr/news/articleView.html?idxno=95551
822,2019-11-22,SK바이오팜뇌전증신약엑스코프리FDA승인독자개발신약으로는한국최초성과,http://www.thebigdata.co.kr/view.php?ud=201911221112545648d0a8833aad_23
823,2019-11-22,몸값최소5조SK바이오팜상장청신호바이오주랠리,http://news.heraldcorp.com/view.php?ud=20191122000298
824,2019-11-22,SK바이오팜38조시장뚫었다독자개발뇌전증신약美허가,http://news.mt.co.kr/mtview.php?no=2019112210321469833
825,2019-11-22,SK바이오팜개발뇌전증신약엑스코프리美FDA승인,http://www.medigatenews.com/news/2320840829
826,2019-11-22,SK바이오랜드주가상승세FDA시판허가SK바이오팜영향,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20191122.99099009907
827,2019-11-22,sk바이오랜드최고상한가이유는sk바이오팜뇌전증신약품목허가영향,http://www.ccreview.co.kr/news/articleView.html?idxno=218487
828,2019-11-22,SK바이오팜독자개발뇌전증신약미국시장뚫었다,http://www.seoulfn.com/news/articleView.html?idxno=363296
829,2019-11-22,SK바이오팜뇌전증신약美FDA판매허가,http://www.bokuennews.com/news/article.html?no=183618
830,2019-11-22,SK바이오팜독자개발뇌전증신약엑스코프리美FDA시판허가,http://4th.kr/View.aspx?No=330480
831,2019-11-22,SK바이오팜올해만미국허가2건남은물질6개,http://www.dailypharm.com/Users/News/NewsView.html?ID=259218&REFERER=NP
832,2019-11-22,SK바이오팜뇌전증신약미국FDA허가,https://science.ytn.co.kr/program/program_view.php?s_mcd=0082&s_hcd=&key=201911221125109957
833,2019-11-22,SK바이오팜뇌전증치료신약으로미FDA허가,http://www.hani.co.kr/arti/economy/marketing/918091.html
834,2019-11-22,최태원뚝심통했다美FDA뚫은SK바이오팜독자개발뇌전증신약,http://www.etoday.co.kr/news/section/newsview.php?idxno=1825515
835,2019-11-22,SK바이오팜독자개발뇌전증신약美FDA승인,http://daily.hankooki.com/lpage/ittech/201911/dh20191122140258145630.htm
836,2019-11-22,최태원회장27년바이오뚝심SK바이오팜의성과로일궈,http://sports.chosun.com/news/ntype.htm?id=201911230100187050012580&servicedate=20191122
837,2019-11-22,SK바이오팜27년결실거뒀다,http://www.smedaily.co.kr/news/articleView.html?idxno=87752
838,2019-11-22,SK바이오팜뇌전증신약美FDA승인국내첫독자개발신약결실,http://www.thevaluenews.co.kr/news/view.php?idx=157475
839,2019-11-22,SK바이오팜독자개발뇌전증신약美FDA시판허가,http://news.kmib.co.kr/article/view.asp?arcid=0013957770&code=61171811&cp=nv
840,2019-11-22,그래픽SK바이오팜엑스코프리개발일지,http://yna.kr/GYH20191122000500044?did=1363m
841,2019-11-22,SK바이오팜독자개발엑스코프리美허가,http://www.finomy.com/news/articleView.html?idxno=72040
842,2019-11-22,SK바이오랜드SK바이오팜美FDA시판허가소식에상한가,http://moneys.mt.co.kr/news/mwView.php?no=2019112214558078338
843,2019-11-22,IPO기자간담회브릿지바이오제2의SK바이오팜될것,http://www.metroseoul.co.kr/news/newsview?newscd=2019112200092
844,2019-11-22,최태원SK회장의바이오비전27년만에신약결실최윤정근무SK바이오팜관심커졌다,http://www.greened.kr/news/articleView.html?idxno=224765
845,2019-11-22,메지온에이치엘비SK바이오팜이어미국식품의약국문턱넘을까,http://www.businesspost.co.kr/BP?command=article_view&num=152268
846,2019-11-22,SK바이오팜뇌전증신약美승인국내최초FDA관문넘어,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1074412
847,2019-11-22,SK바이오팜신약개발성공내년초IPO대어등극,http://fn.segye.com/content/html/2019/11/22/20191122509386.html?OutUrl=naver
848,2019-11-22,신약결실SK바이오팜IPO기대감↑계열사주가도상한가,http://www.dailian.co.kr/news/view/845970/?sc=naver
849,2019-11-22,SK바이오팜신약美FDA승인에IPO기대감up,http://www.sisajournal-e.com/news/articleView.html?idxno=209433
850,2019-11-22,위클리제약바이오SK바이오팜뇌전증혁신신약미국FDA승인획득外,http://www.etoday.co.kr/news/section/newsview.php?idxno=1825605
851,2019-11-22,급등락주짚어보기SK바이오팜미신약승인SK바이오랜드상한가인트로메딕5일째급락,http://www.etoday.co.kr/news/section/newsview.php?idxno=1825654
852,2019-11-22,SK바이오팜덕분에SK바이오랜드급등,http://www.newstomato.com/ReadNews.aspx?no=935286
853,2019-11-22,SK자회사SK바이오팜독자개발뇌전증신약미국식품의약국판매승인,http://www.viva100.com/main/view.php?key=20191122010007861
854,2019-11-22,SK바이오팜쾌거에국내증시바이오株기대감확산종합,http://yna.kr/AKR20191122045251008?did=1195m
855,2019-11-22,최태원회장의뚝심SK바이오팜뇌전증신약엑스코프리FDA승인,http://sports.hankooki.com/lpage/economy/201911/sp20191122165135137020.htm
856,2019-11-22,SK바이오팜독자개발뇌전증혁신신약美FDA승인,http://www.dailymedi.com/detail.php?number=849862&thread=22r05
857,2019-11-22,fn사설SK바이오팜개가신약강국의길은열려있다,http://www.fnnews.com/news/201911221703078924
858,2019-11-22,SK바이오팜독자개발뇌전증신약미국FDA시판허가,https://cnbc.sbs.co.kr/article_hub/10000963336?division=NAVER
859,2019-11-22,SK바이오팜신약72조시장황금알낳는거위로,https://www.sedaily.com/NewsView/1VQWBS63MR
860,2019-11-22,SK바이오팜미국서K바이오새역사썼다,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201911220162&t=NNv
861,2019-11-22,SK바이오팜엑스코프리국내최초독자개발로美FDA승인,http://news.kmib.co.kr/article/view.asp?arcid=0013958478&code=61141411&cp=nv
862,2019-11-22,성인환자부분발작치료제SK바이오팜엑스코프리SK바이오팜뇌전증신약美FDA승인,http://www.fnnews.com/news/201911221749585730
863,2019-11-22,SK바이오팜내년초IPO대박예감母회사SK주가에도호재SK바이오팜뇌전증신약美FDA승인,http://www.fnnews.com/news/201911221750019571
864,2019-11-22,실패에도과감한투자혁신과패기열정이혁신밑거름SK바이오팜뇌전증신약美FDA승인,http://www.fnnews.com/news/201911221750006190
865,2019-11-22,2018년임상3상서엑스코프리복용환자뇌전증발작빈도감소확인SK바이오팜뇌전증신약美FDA승인,http://www.fnnews.com/news/201911221749599322
866,2019-11-22,오늘이슈지난해기업순이익64감소靑지소미아조건부종료연기홍콩시위소강세SK바이오팜FDA시판허가자본시장규제30건개선시진핑美와1단계협정체결노력,http://www.econovill.com/news/articleView.html?idxno=378278
867,2019-11-22,SK바이오팜독자개발뇌전증신약美FDA판매허가,http://www.thedailypost.kr/news/articleView.html?idxno=71491
868,2019-11-22,서울와이어오늘의주요뉴스지소미아종료유예SK바이오팜국내첫독자개발신약김학의전차관무죄등,http://www.seoulwire.com/news/articleView.html?idxno=258931
869,2019-11-22,주식해결사SK바이오팜신약FDA허가SK바이오랜드급등,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019112217195150216
870,2019-11-22,SK바이오팜신약엑스코프리미국FDA승인,https://asiatime.co.kr/news/newsview.php?ncode=1065605922126642
871,2019-11-22,최태원27년뚝심SK美FDA넘었다SK바이오팜뇌전증신약美FDA승인,http://www.fnnews.com/news/201911222005147379
872,2019-11-22,SK바이오팜뇌전증신약국내첫FDA직접판매허가,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201911222107015&code=920501
873,2019-11-22,최태원회장뚝심SK바이오팜뇌전증신약FDA시판허가결실,http://www.queen.co.kr/news/articleView.html?idxno=322359
874,2019-11-22,SK바이오팜혁신신약미국FDA시판허가받아1993년이래최태원회장의꿈결실,http://www.kdpress.co.kr/news/articleView.html?idxno=93565
875,2019-11-22,SK바이오팜뇌전증신약미국FDA승인최태원회장바이오뚝심한국최초독자개발신약결실,http://www.econonews.co.kr/news/articleView.html?idxno=95598
876,2019-11-23,SK바이오팜독자개발신약미FDA허가,http://news.joins.com/article/olink/23234255
877,2019-11-23,SK바이오팜IPO구주매출비중관심↑,http://www.newstomato.com/ReadNews.aspx?no=935316
878,2019-11-23,최태원뚝심이만든SK바이오팜뇌전증신약화제,http://www.anewsa.com/detail.php?number=2021997&thread=10r02
879,2019-11-23,SK바이오팜에SK주가직격탄장대음봉에대량거래주가회복언제쯤,http://www.g-enews.com/ko-kr/news/article/news_all/2019112306254499534e4869c120_1/article.html
880,2019-11-23,SK바이오팜뇌전증혁신신약엑스코프리美FDA시판허가독자개발첫성과,http://www.newsinside.kr/news/articleView.html?idxno=1048648
881,2019-11-23,SK바이오팜FDA승인예상성장규모보니화들짝,http://www.ccreview.co.kr/news/articleView.html?idxno=218564
882,2019-11-23,SK바이오팜신약개발성공에IPO대어급부상,http://www.cstimes.com/?mod=news&act=articleView&idxno=321508
883,2019-11-23,SK바이오팜독자개발뇌전증신약미국FDA허가,http://www.polinews.co.kr/news/article.html?no=435474
884,2019-11-23,SK바이오팜국내증시에쏘아올린2개의공,https://www.hankyung.com/economy/article/2019112380827
885,2019-11-24,제약바이오이모저모SK바이오팜독자개발뇌전증신약美FDA시판허가,http://www.edaily.co.kr/news/newspath.asp?newsid=01134886622689000
886,2019-11-24,SK바이오팜상장팔부능선넘었다,http://www.newstomato.com/ReadNews.aspx?no=935179
887,2019-11-24,뉴투분석SK바이오팜이혁신신약성과낸이유는,http://www.news2day.co.kr/142648
888,2019-11-24,SK바이오팜몸값최소5조원2년여만에등장한IPO대물,http://yna.kr/AKR20191123025000008?did=1195m
889,2019-11-24,바이오시계빨라지는SK바이오팜매출1조클럽가나,http://www.viva100.com/main/view.php?key=20191124010008059
890,2019-11-24,SK바이오팜코스피상장IPO시장활력되찾나몸값최소5조원”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1825836
891,2019-11-24,SK바이오팜기업가치5조뇌전증신약이뭐길래,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201911240019&t=NN
892,2019-11-24,IPO최대어SK바이오팜상장이후몸값최소5조원,http://www.newsway.co.kr/news/view?tp=1&ud=2019112410304672240
893,2019-11-24,5조원대어SK바이오팜IPO시장활기불어넣을까,https://www.hankyung.com/economy/article/2019112485867
894,2019-11-24,IPO앞둔SK바이오팜몸값최소5조원2년여만에등장한IPO대물,http://www.getnews.co.kr/view.php?ud=201911241035257415fab1982f6a_16
895,2019-11-24,SK바이오팜몸값최대10조원예상대물등장,http://www.finomy.com/news/articleView.html?idxno=72084
896,2019-11-24,SK바이오팜IPO청신호기업가치최대10조전망,http://www.metroseoul.co.kr/news/newsview?newscd=2019112400098
897,2019-11-24,코스피입성앞둔SK바이오팜FDA허가겹경사,http://www.econovill.com/news/articleView.html?idxno=378267
898,2019-11-24,철저한현지화승리조정우SK바이오팜사장의美FDA공략법,http://www.edaily.co.kr/news/newspath.asp?newsid=01797446622689000
899,2019-11-24,SK바이오팜몸값최소5조2년來최대어,https://www.hankyung.com/finance/article/2019112490131
900,2019-11-24,美FDA날개단SK바이오팜시총최소5조,http://news.mk.co.kr/newsRead.php?year=2019&no=977822
901,2019-11-24,SK바이오팜혁신신약FDA판매허가최태원딥체인지성과,http://www.ajunews.com/view/20191124084945172
902,2019-11-24,SK바이오팜상장시최대8조세노바메이트만55조,https://view.asiae.co.kr/article/2019112418333349265
903,2019-11-24,SK바이오랜드SK바이오팜신약FDA품목허가소식에상한가마감,http://www.mdtoday.co.kr/mdtoday/index.html?no=370944
904,2019-11-25,SK바이오팜몸값최대10조원5년내최대어,https://www.asiatime.co.kr/news/newsview.php?ncode=1065625026819990
905,2019-11-25,초점다시부는바이오바람SK바이오팜등IPO주목,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1074463
906,2019-11-25,SKSK바이오팜FDA판매승인은주가상승요인대신,http://www.edaily.co.kr/news/newspath.asp?newsid=01380886622689328
907,2019-11-25,SK바이오팜독자개발뇌전증신약FDA허가,http://weekly.hankooki.com/lpage/economy/201911/wk20191125080051146400.htm
908,2019-11-25,SK바이오팜시판허가바이오업종투심회복기대”하나금융,http://www.etoday.co.kr/news/section/newsview.php?idxno=1825993
909,2019-11-25,하나금투SK바이오팜시총6∼8조원규모기대,http://yna.kr/AKR20191125020800008?did=1195m
910,2019-11-25,SKSK바이오팜신약시판허가주가상승요인매수대신증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1826004
911,2019-11-25,HotLineSK바이오팜의뇌전증신약미국서최대1조원이상팔릴것,http://news.mk.co.kr/newsRead.php?year=2019&no=978692
912,2019-11-25,SK주식매수의견유지SK바이오팜신약미국판매허가호재,http://www.businesspost.co.kr/BP?command=article_view&num=152409
913,2019-11-25,증시키워드SK바이오팜효과SK바이오랜드↑임상불안감필룩스에이치엘비↓,http://www.etoday.co.kr/news/section/newsview.php?idxno=1826014
914,2019-11-25,하나금투SK바이오팜시총6∼8조원전망,http://www.smedaily.co.kr/news/articleView.html?idxno=87772
915,2019-11-25,대신證SK자회사SK바이오팜신약매출1조원이상전망,http://www.viva100.com/main/view.php?key=20191125010008276
916,2019-11-25,SKSK바이오팜신약美시판허가등투자자관심지속전망,http://www.asiatoday.co.kr/view.php?key=20191125010013996
917,2019-11-25,하나금융투자SK바이오팜시총6∼8조원규모기대,http://www.paxetv.com/news/articleView.html?idxno=82139
918,2019-11-25,SK바이오팜시총6∼8조원예상하나금투,http://www.seoulfn.com/news/articleView.html?idxno=363417
919,2019-11-25,하나금투SK바이오팜시가총액6∼8조원규모예상”,http://www.kukinews.com/news/article.html?no=721954
920,2019-11-25,특징주SK바이오랜드SK바이오팜신약FDA품목허가소식에급등,http://www.newsis.com/view/?id=NISX20191125_0000839681&cID=10401&pID=10400
921,2019-11-25,특징주SK바이오랜드SK바이오팜신약FDA허가에이틀째급등,http://www.edaily.co.kr/news/newspath.asp?newsid=01925366622689328
922,2019-11-25,최태원의뚝심SK바이오팜독자개발뇌전증신약FDA허가,https://jhealthmedia.joins.com/article/article_view.asp?pno=21123
923,2019-11-25,SK바이오랜드SK바이오팜신약FDA허가에이틀째급등,http://www.mdtoday.co.kr/mdtoday/index.html?no=370967
924,2019-11-25,SK바이오랜드SK바이오팜신약美판매허가에이틀째급등,https://biz.chosun.com/site/data/html_dir/2019/11/25/2019112500709.html?utm_source=naver&utm_medium=original&utm_campaign=biz
925,2019-11-25,제약바이오SK바이오팜시판허가획득으로활기되찾을것”하나금융투자,http://www.fntimes.com/html/view.php?ud=2019112509175286446c0eb6f11e_18
926,2019-11-25,특징주SK바이오랜드SK바이오팜美신약판매허가에이틀째강세,http://www.viva100.com/main/view.php?key=20191125010008337
927,2019-11-25,하나금투SK바이오팜제약바이오활기불러와시총68조원,http://www.seoulwire.com/news/articleView.html?idxno=259190
928,2019-11-25,SK바이오랜드SK바이오팜신약FDA허가소식에급등세52주신고가,http://www.seoulwire.com/news/articleView.html?idxno=259192
929,2019-11-25,SK바이오랜드SK바이오팜신약FDA허가에급등세지속52주신고가,http://www.betanews.net:8080/article/1104989.html
930,2019-11-25,SK바이오팜연관없는데도SK바이오랜드장중52주신고가경신,https://www.hankyung.com/finance/article/2019112500266
931,2019-11-25,SK바이오랜드SK케미칼상승에27폭등까지SK바이오팜효과,http://www.econonews.co.kr/news/articleView.html?idxno=95829
932,2019-11-25,SK바이오팜미국매출기대SK장중주가다시반등,http://www.choicenews.co.kr/news/articleView.html?idxno=65986
933,2019-11-25,특징주SK바이오랜드SK바이오팜신약허가에급등지속신고가,http://inthenews.co.kr/article-25598/
934,2019-11-25,특징주SK바이오랜드SK바이오팜신약FDA허가에급등,http://www.ebn.co.kr/news/view/1010615/?sc=naver
935,2019-11-25,특징주SK바이오팜호재SK바이오랜드급등세지속,http://news1.kr/articles/?3777180
936,2019-11-25,바이오IPO시장SK바이오팜훈풍기대,http://www.choicenews.co.kr/news/articleView.html?idxno=65992
937,2019-11-25,리포트브리핑SKSK바이오팜뇌전증신약미국시판허가목표가320000원대신증권,http://www.newspim.com/news/view/20191125000559
938,2019-11-25,SK바이오팜신약개발로매출실현선례만든다,http://medipana.com/news/news_viewer.asp?NewsNum=249163&MainKind=A&NewsKind=5&vCount=12&vKind=1
939,2019-11-25,상장전대박터트린SK바이오팜韓바이오희망되나,https://asiatime.co.kr/news/newsview.php?ncode=1065588551561683
940,2019-11-25,SKSK바이오팜뇌전증신약미국FDA시판허가획득”,http://www.wikitree.co.kr/main/news_view.php?id=483795
941,2019-11-25,IPO초대어SK바이오팜내년상장바이오시장호재,http://www.viva100.com/main/view.php?key=20191125010008527
942,2019-11-25,SK바이오팜FDA승인소식에SK바이오랜드가왜상한가,http://daily.hankooki.com/lpage/economy/201911/dh20191125154223138110.htm
943,2019-11-25,더벨SK바이오팜IPO청신호글로벌3상악몽없다,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201911220100042770002646
944,2019-11-25,급등락주짚어보기SK바이오팜FDA승인에SK바이오랜드연속급등센트랄모텍상장첫날상한가,http://www.etoday.co.kr/news/section/newsview.php?idxno=1826385
945,2019-11-25,SK바이오팜과상관없는데급등SK바이오랜드투자주의,https://www.sedaily.com/NewsView/1VQXQ07DHT
946,2019-11-25,최태원혜안빛났다힘받는SK바이오팜상장주목,http://www.whitepaper.co.kr/news/articleView.html?idxno=182583
947,2019-11-25,SK바이오팜몸값최소5조원IPO대어기대감상승,http://www.economytalk.kr/news/articleView.html?idxno=201371
948,2019-11-25,SK바이오랜드주가의아한상한가SK바이오팜무관한데급등,http://www.businesspost.co.kr/BP?command=article_view&num=152567
949,2019-11-25,SK바이오팜뇌전증신약美진출쾌거다음타자는,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019112517101125231
950,2019-11-25,조정우SK바이오팜은세상에없는혁신신약개발로계속간다,http://www.businesspost.co.kr/BP?command=article_view&num=152544
951,2019-11-25,SK바이오팜상장땐최대10조IPO시장훈풍부나,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201911252121035&code=920501
952,2019-11-26,SK바이오팜상장그룹지배구조개편신호탄,https://www.ajunews.com/view/20191125155115146
953,2019-11-26,SK바이오팜삼바셀트리온헬스케어잇는대어될까,http://news1.kr/articles/?3777754
954,2019-11-26,한입뉴스한인니자동차부품무관세서울아파트구입30대가큰손데이터3법국회본회의통과불투명쇠고기마블링적어도투플러스갤럭시S11카메라사양기능대폭강화SK바이오팜내년1월쯤코스피상장내년살림더팍팍해,http://www.econovill.com/news/articleView.html?idxno=378450
955,2019-11-26,SK바이오팜뇌전증혁신신약엑스코프리美FDA승인,http://www.newsian.co.kr/news/articleView.html?idxno=37952
956,2019-11-26,SK바이오랜드의이유없는급등SK바이오팜상장주목,http://www.ajunews.com/view/20191126083719485
957,2019-11-26,증시키워드SK바이오팜신약개발에바이오주들썩센트랄모텍상장첫날↑,http://www.etoday.co.kr/news/section/newsview.php?idxno=1826563
958,2019-11-26,SK바이오팜씨제이헬스등상장앞두고몸값관심,http://www.dailymedi.com/detail.php?number=849967&thread=22r05
959,2019-11-26,조정우사장SK바이오팜글로벌제약사발돋움뇌전증신약내년2분기美출시”,http://www.viva100.com/main/view.php?key=20191126010008864
960,2019-11-26,AT현장조정우SK바이오팜사장FDA승인은효능과안정성입증한것,https://www.asiatime.co.kr/news/newsview.php?ncode=1065575304860816
961,2019-11-26,SK바이오팜엑스코프리미국FDA승인간담회,http://www.newsis.com/view/?id=NISI20191126_0015843708
962,2019-11-26,SK바이오팜엑스코프리미국FDA승인기자간담회,http://www.newsis.com/view/?id=NISI20191126_0015843711
963,2019-11-26,기자간담회하는조정우SK바이오팜사장,http://www.newsis.com/view/?id=NISI20191126_0015843709
964,2019-11-26,SK바이오팜엑스코프리미국FDA승인간담회,http://www.newsis.com/view/?id=NISI20191126_0015843714
965,2019-11-26,SK바이오팜뇌전증치료제내년2분기美출시,http://www.monews.co.kr/news/articleView.html?idxno=206714
966,2019-11-26,AT현장조정우SK바이오팜사장엑스코프리유럽판매해외기업통해진행예정,https://www.asiatime.co.kr/news/newsview.php?ncode=1065577648102848
967,2019-11-26,기자간담회하는조정우SK바이오팜사장,http://www.newsis.com/view/?id=NISI20191126_0015843710
968,2019-11-26,NW포토뇌전증치료제엑스코프리소개하는조정우SK바이오팜사장,http://www.newsway.co.kr/news/view?tp=1&ud=2019112610552029041
969,2019-11-26,NW포토엑스코프리FDA승인밝히는조정우SK바이오팜사장,http://www.newsway.co.kr/news/view?tp=1&ud=2019112610564558987
970,2019-11-26,조정우SK바이오팜사장엑스코프리영업사원110명과미국공략한다,http://moneys.mt.co.kr/news/mwView.php?no=2019112610518088800
971,2019-11-26,SK바이오팜엑스코프리FDA승인기자간담회,http://yna.kr/PYH20191126078500013?did=1196m
972,2019-11-26,SK바이오팜엑스코프리FDA승인기자간담회,http://yna.kr/PYH20191126078500013?did=1196m
973,2019-11-26,조정우SK바이오팜사장엑스코프리관련기자간담회,http://yna.kr/PYH20191126081900013?did=1196m
974,2019-11-26,기자간담회하는조정우SK바이오팜사장,http://yna.kr/PYH20191126080700013?did=1196m
975,2019-11-26,SK바이오팜의뇌전증신약미국FDA허가,http://yna.kr/PYH20191126080400013?did=1196m
976,2019-11-26,조정우SK바이오팜사장엑스코프리관련기자간담회,http://yna.kr/PYH20191126082000013?did=1196m
977,2019-11-26,NW포토조정우SK바이오팜사장엑스코프리美FDA승인은효능안정성입증한것”,http://www.newsway.co.kr/news/view?tp=1&ud=2019112610591573895
978,2019-11-26,조정우SK바이오팜대표뇌전증신약美전역서직판한다,https://www.hankyung.com/finance/article/2019112631366
979,2019-11-26,SK바이오팜상장에바이오株살아날까,https://view.asiae.co.kr/article/2019112611102042687
980,2019-11-26,SK바이오팜뇌전증신약내년2Q출시세계최대제약시장진출,http://www.newsis.com/view/?id=NISX20191126_0000841367&cID=13001&pID=13000
981,2019-11-26,SK바이오팜사장뇌전증신약내년2분기美출시바이오항암제도개발,http://news.einfomax.co.kr/news/articleView.html?idxno=4058523
982,2019-11-26,포토글로벌진출계획밝히는조정우SK바이오팜사장,http://www.sisafocus.co.kr/news/articleView.html?idxno=226520
983,2019-11-26,SK바이오팜美FDA승인엑스코프리판매준비는완료됐다”,http://www.kukinews.com/news/article.html?no=722396
984,2019-11-26,조정우SK바이오팜사장엑스코프리美DEA최종허가후내년출시”,http://daily.hankooki.com/lpage/ittech/201911/dh20191126112017145630.htm
985,2019-11-26,SK바이오팜뇌전증치료제엑스코프리내년2분기미국전역직판,http://www.newspim.com/news/view/20191126000613
986,2019-11-26,조정우SK바이오팜사장엑스코프리내년2분기美출시5조시장도전”,http://www.ajunews.com/view/20191126110901726
987,2019-11-26,SK바이오팜엑스코프리美법인통해직접마케팅,https://www.paxnetnews.com/articles/54230
988,2019-11-26,SK바이오팜독자개발뇌전증신약적응증확대추진,https://www.nocutnews.co.kr/news/5249547
989,2019-11-26,포토美진출계획밝히는조정우SK바이오팜사장,http://biz.newdaily.co.kr/site/data/html/2019/11/26/2019112600083.html
990,2019-11-26,SK바이오팜엑스코프리미FDA승인글로벌기업목표,http://www.whosaeng.com/114220
991,2019-11-26,SK바이오팜내년상반기상장할것,https://view.asiae.co.kr/article/2019112612011575625
992,2019-11-26,조정우SK바이오팜사장엑스코프리내년2분기미국시장공략,http://www.asiatoday.co.kr/view.php?key=20191126010015232
993,2019-11-26,SK바이오팜국내최초美직판체계구축엑스코프리직접판다,http://www.viva100.com/main/view.php?key=20191126010008939
994,2019-11-26,SK바이오팜조정우대표수많은실패속신약성공내년2분기美판매,https://biz.chosun.com/site/data/html_dir/2019/11/26/2019112601470.html?utm_source=naver&utm_medium=original&utm_campaign=biz
995,2019-11-26,조정우SK바이오팜사장뇌전증신약엑스코프리미국성공이유있다,http://www.sportsseoul.com/news/read/853734
996,2019-11-26,포토SK바이오팜엑스코프리美DEA최종허가후2020년2분기미국출시,http://www.sisafocus.co.kr/news/articleView.html?idxno=226539
997,2019-11-26,SK바이오팜내년2분기엑스코프리美직접출격채비,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=237853
998,2019-11-26,SK바이오팜뇌전증치료제엑스코프리미국공략,http://www.dailypharm.com/Users/News/NewsView.html?ID=259346&REFERER=NP
999,2019-11-26,조정우SK바이오팜사장엑스코프리FDA승인은국내제약산업에한획을그은것,http://www.sisafocus.co.kr/news/articleView.html?idxno=226544
1000,2019-11-26,뇌전증신약미FDA승인역사쓴SK바이오팜미국직판에도도전장,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1074523
1001,2019-11-26,조정우SK바이오팜대표엑스코프리적응증확대해시장키워갈것,http://news.mk.co.kr/newsRead.php?year=2019&no=984993
1002,2019-11-26,SK바이오팜뇌전증신약엑스코프리내년2분기미국시장출시,http://www.fnnews.com/news/201911261308054706
1003,2019-11-26,SK바이오팜세계최대제약시장공략채비마쳤다내년2분기미국직판,http://www.etoday.co.kr/news/section/newsview.php?idxno=1826776
1004,2019-11-26,SK바이오팜뇌전증신약내년2분기미국서판매,https://jhealthmedia.joins.com/article/article_view.asp?pno=21130
1005,2019-11-26,조정우SK바이오팜사장뇌전증신약내년2분기美출시직판가동,http://biz.newdaily.co.kr/site/data/html/2019/11/26/2019112600089.html
1006,2019-11-26,SK바이오팜엑스코프리TM완전발작소실사례다수,http://www.bosa.co.kr/news/articleView.html?idxno=2116732
1007,2019-11-26,조정우SK바이오팜사장엑스코프리FDA승인한국제약산업이정표,http://www.ebn.co.kr/news/view/1010837/?sc=naver
1008,2019-11-26,SK바이오팜엑스코프리美직판준비완료내년2분기출시,http://news.mt.co.kr/mtview.php?no=2019112611164146930
1009,2019-11-26,SK바이오팜국내첫독자개발뇌전증신약내년2분기미국서직접판다,http://www.etnews.com/20191126000158
1010,2019-11-26,SK바이오팜뇌전증신약美직판수익극대화최회장께감사,http://www.upinews.kr/newsView/upi201911260063
1011,2019-11-26,SK바이오팜국내증시상장투자심리살아날것,http://www.mdtoday.co.kr/mdtoday/index.html?no=371107
1012,2019-11-26,SK바이오팜뇌전증신약엑스코프리美FDA승인내년2분기출시,http://www.lawissue.co.kr/view.php?ud=201911261425383883f4ab64559d_12
1013,2019-11-26,조정우SK바이오팜뇌전증신약을내년2분기에미국에출시,http://www.businesspost.co.kr/BP?command=article_view&num=152671
1014,2019-11-26,AT현장SK바이오팜엑스코프리美유통라인구축완료내년2분기출시,https://www.asiatime.co.kr/news/newsview.php?ncode=1065588484471590
1015,2019-11-26,인사이드스토리글로벌신약새역사쓴SK바이오팜,http://news.bizwatch.co.kr/article/consumer/2019/11/26/0006/naver
1016,2019-11-26,SK바이오팜엑스코프리부작용대비효과뛰어난뇌전증신약치료제,http://www.getnews.co.kr/view.php?ud=2019112614210869141d0c69529_16
1017,2019-11-26,조정우SK바이오팜사장엑스코프리FDA허가최태원회장께감사,http://www.newspost.kr/news/articleView.html?idxno=73997
1018,2019-11-26,SK바이오팜엑스코프리승인코스피입성준비,http://www.shinailbo.co.kr/news/articleView.html?idxno=1227266
1019,2019-11-26,조정우SK바이오팜대표엑스코프리다음목표는바이오신약”,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=004&oid=050&aid=0000052078
1020,2019-11-26,SK바이오팜조정우사장엑스코프리내년2분기부터美전역직접판매,http://www.metroseoul.co.kr/news/newsview?newscd=2019112600138
1021,2019-11-26,SK바이오팜7조뇌전증시장본격출사표,http://www.koreastocknews.com/news/articleView.html?idxno=48350
1022,2019-11-26,SK바이오팜7조뇌전증시장본격출사표,http://www.koreastocknews.com/news/articleView.html?idxno=48350
1023,2019-11-26,조정우SK바이오팜사장엑스코프리뇌전증리딩브랜드로키우겠다”,http://www.hankookilbo.com/news/npath/201911261530769516?did=NA
1024,2019-11-26,SK바이오팜뇌전증신약내년美판매최태원회장뚝심성과,http://www.ichannela.com/news/main/news_detailPage.do?publishId=000000176972
1025,2019-11-26,SK바이오팜엑스코프리美내년2분기출시”,http://www.sentv.co.kr/news/view/564645
1026,2019-11-26,SK바이오팜뇌전증신약내년미국출시,http://www.smedaily.co.kr/news/articleView.html?idxno=87832
1027,2019-11-26,조정우SK바이오팜사장뇌전증신약내년2분기美서출시,http://www.seoulwire.com/news/articleView.html?idxno=260112
1028,2019-11-26,SK바이오팜독자개발신약영업도직접한다,http://www.newstomato.com/ReadNews.aspx?no=935889
1029,2019-11-26,SK바이오팜뇌전증신약추후환자95까지타깃,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58391
1030,2019-11-26,SK바이오팜엑스코프리美FDA승인뇌전증환자삶의질개선,http://www.newsprime.co.kr/news/article.html?no=484651
1031,2019-11-26,미국에서신약허가받은SK바이오팜본격상장들어가나,http://www.sisajournal-e.com/news/articleView.html?idxno=209587
1032,2019-11-26,조정우SK바이오팜사장엑스코프리FDA승인숱한실패이겨낸결과,http://news.tf.co.kr/read/economy/1769501.htm
1033,2019-11-26,NW포토SK바이오팜엑스코프리성과말하는이상건서울대병원신경과교수,http://www.newsway.co.kr/news/view?tp=1&ud=2019112615564263422
1034,2019-11-26,SK우선주3년만에첫상한가SK바이오팜효과,http://www.ajunews.com/view/20191126155832041
1035,2019-11-26,뉴스웨이TVFDA승인뇌전증신약SK바이오팜대박최태원회장의다음타자는,http://www.newsway.co.kr/news/view?tp=1&ud=2019112616014151778
1036,2019-11-26,SK바이오팜수노시에이어엑스코프리까지FDA허가획득글로벌혁신신약기업으로우뚝선다,http://www.segye.com/content/html/2019/11/26/20191126510983.html?OutUrl=naver
1037,2019-11-26,SK바이오팜엑스코프리내년상반기미국출시,http://www.news2day.co.kr/142880
1038,2019-11-26,롤러코스터SK바이오랜드SK바이오팜과무관,http://www.newstomato.com/ReadNews.aspx?no=935939
1039,2019-11-26,SK바이오팜뇌전증신약엑스코프리내년2분기美출시,http://www.newsian.co.kr/news/articleView.html?idxno=37992
1040,2019-11-26,SK바이오팜엑스코프리2020년2분기미국출시목표세계최대제약시장진출,http://sports.khan.co.kr/news/sk_index.html?art_id=201911261705023&sec_id=561801&pt=nv
1041,2019-11-26,조정우대표SK바이오팜내년상반기상장목표,http://www.edaily.co.kr/news/newspath.asp?newsid=03968806622689656
1042,2019-11-26,SK바이오팜혁신신약으로美시장공략채비,http://www.fnnews.com/news/201911261727008063
1043,2019-11-26,SK바이오팜직판체제로미국시장공략,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201911260321&t=NNv
1044,2019-11-26,SK바이오팜조정우대표엑스코프리대한민국제약산업에한획그을것,http://www.dailian.co.kr/news/view/846983/?sc=naver
1045,2019-11-26,SK바이오팜뇌전증신약내년부터美판매,http://news.mk.co.kr/newsRead.php?year=2019&no=987024
1046,2019-11-26,SK바이오팜제약바이오본고장美본격공략,http://www.dt.co.kr/contents.html?article_no=2019112702101531102001&ref=naver
1047,2019-11-26,조정우SK바이오팜사장엑스코프리7조글로벌시장공략,http://www.finomy.com/news/articleView.html?idxno=72203
1048,2019-11-26,SK바이오팜뇌전증신약엑스코프리내년2분기미국서판매,http://www.cstimes.com/?mod=news&act=articleView&idxno=321835
1049,2019-11-27,SK바이오팜엑스코프리FDA승인철저히준비된그룹지배구조개편,https://www.ajunews.com/view/20191126172411152
1050,2019-11-27,기자의눈SK바이오팜신뢰와혁신의무형자산,http://www.dailypharm.com/Users/News/NewsView.html?ID=259359&REFERER=NP
1051,2019-11-27,美FDA관문넘은SK바이오팜기업가치는,http://www.mdtoday.co.kr/mdtoday/index.html?no=371165
1052,2019-11-27,더벨SK바이오팜바이오로영토확장키워드는뇌질환,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201911260100048860003002
1053,2019-11-27,조정우SK바이오팜사장엑스코프리내년2분기미국판매,http://www.seoulfn.com/news/articleView.html?idxno=363693
1054,2019-11-27,SK바이오팜엑스코프리내년미국서판매,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3994826
1055,2019-11-27,inoutSK바이오팜②CNS치료제이어파이프라인확충심혈,http://www.econovill.com/news/articleView.html?idxno=378533
1056,2019-11-27,inoutSK바이오팜③따로또같이”SK제약바이오역사,http://www.econovill.com/news/articleView.html?idxno=378548
1057,2019-11-27,inoutSK바이오팜①신약엑스코프리글로벌CNS시장겨냥,http://www.econovill.com/news/articleView.html?idxno=378532
1058,2019-11-27,SK바이오팜잡은NH證한투證대박수익기대,https://www.paxnetnews.com/articles/54200
1059,2019-11-27,조정우SK바이오팜사장20년꿈이현실로최태원회장지원덕”,https://www.ajunews.com/view/20191126144124920
1060,2019-11-27,SK바이오팜내년상반기상장확실시기업가치는8조원,http://news.tf.co.kr/read/economy/1769586.htm
1061,2019-11-27,조현병조울증치료제등개발속도SK바이오팜제2엑스코프리준비,http://news.heraldcorp.com/view.php?ud=20191127000472
1062,2019-11-27,빡쎈뉴스SK바이오팜내년미국출시준비완료글로벌제약사와어깨나란히,http://www.paxetv.com/news/articleView.html?idxno=82349
1063,2019-11-27,SK바이오랜드SK바이오팜美FDA뇌전증신약허가소식에연일상한가,http://www.mdtoday.co.kr/mdtoday/index.html?no=371220
1064,2019-11-27,SK바이오팜셀트리온글로벌직판체제시험대수익성확대기대,http://biz.newdaily.co.kr/site/data/html/2019/11/27/2019112700112.html
1065,2019-11-27,SK바이오팜엑스코프리내년미국서판매,http://www.mbn.co.kr/pages/vod/programContents.php?progCode=683&menuCode=4385&bcastSeqNo=1229095
1066,2019-11-27,SK바이오팜이어SK케미칼도미국FDA허들넘었다,http://news.bizwatch.co.kr/article/consumer/2019/11/27/0007/naver
1067,2019-11-27,셀트리온SK바이오팜근거있는직판,http://www.newstomato.com/ReadNews.aspx?no=936207
1068,2019-11-27,75만국내환자도기다린다SK바이오팜뇌전증신약국내언제나오나,http://www.edaily.co.kr/news/newspath.asp?newsid=03588326622689984
1069,2019-11-27,SK바이오팜독자개발한뇌전증신약제약사최초로美FDA승인,http://www.ekn.kr/news/article.html?no=465368
1070,2019-11-27,조정우SK바이오팜사장FDA승인승인받은엑스코프리내년2분기미국출시,http://www.ekn.kr/news/article.html?no=466134
1071,2019-11-27,SK바이오팜신약에이어국내최초직판체제이룩달성할것,http://www.k-health.com/news/articleView.html?idxno=46380
1072,2019-11-28,SK바이오팜독자개발신약엑스코프리전신발작적응증확대박차,http://www.ceoscoredaily.com/news/article.html?no=62930
1073,2019-11-28,SK바이오팜뇌전증으로고통받는환자발작소실로삶의질개선할것,http://www.efnews.co.kr/news/articleView.html?idxno=82087
1074,2019-11-28,위축된바이오투심SK바이오팜효과나타날까,http://www.metroseoul.co.kr/news/newsview?newscd=2019112800034
1075,2019-11-28,SK바이오팜잔치에주인SK만소외왜,http://www.newspim.com/news/view/20191128000817
1076,2019-11-28,오늘Who정영채SK바이오팜낚아NH투자증권상장명가입증,http://www.businesspost.co.kr/BP?command=article_view&num=153094
1077,2019-11-28,SK바이오팜뇌전증신약미국직판도전,http://www.wsobi.com/news/articleView.html?idxno=85864
1078,2019-11-29,제약바이오IPO러쉬③투자업계최대어SK바이오팜IPO,http://www.mdtoday.co.kr/mdtoday/index.html?no=371405
1079,2019-11-29,SK바이오팜셀트리온글로벌선전속에삼성바이오로직스에대한기대커지고있어,http://www.techholic.co.kr/news/articleView.html?idxno=187636
1080,2019-12-02,더벨NH증권내년IPO도독무대빅딜SK바이오팜덕,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201911270100053290003287
1081,2019-12-02,NH투자증권SK바이오팜으로내년IPO승기잡는다,http://www.ekn.kr/news/article.html?no=467207
1082,2019-12-03,Invest국내상장SK바이오팜IPO완주열쇠는해외투심,http://www.investchosun.com/?p=3243981
1083,2019-12-03,美진출SK바이오팜엑스코프리국내시장차별성가질까,http://www.monews.co.kr/news/articleView.html?idxno=206838
1084,2019-12-03,SK바이오팜뇌전증신약후보물질IND승인받아,http://moneys.mt.co.kr/news/mwView.php?no=2019120309428024940
1085,2019-12-03,SK바이오팜뇌전증신약물질임상1상FDA승인,https://www.sedaily.com/NewsView/1VRXIBXBYU
1086,2019-12-03,SK바이오팜뇌전증신약美임상1상승인신규뇌전증치료제개발착수,http://www.viva100.com/main/view.php?key=20191203010000786
1087,2019-12-03,SK바이오팜신규뇌전증치료제연구개발본격착수,http://sports.khan.co.kr/news/sk_index.html?art_id=201912030950003&sec_id=561801&pt=nv
1088,2019-12-03,SK바이오팜신규뇌전증치료제美임상1상승인,http://medipana.com/news/news_viewer.asp?NewsNum=249610&MainKind=A&NewsKind=5&vCount=12&vKind=1
1089,2019-12-03,SK바이오팜신규뇌전증치료제연구개발본격착수,http://www.newsway.co.kr/news/view?tp=1&ud=2019120309491474397
1090,2019-12-03,SK바이오팜뇌전증신약SKL24741美FDA임상1상승인받아,http://news1.kr/articles/?3783892
1091,2019-12-03,SK바이오팜신규뇌전증치료제미국1상돌입,http://www.dailypharm.com/Users/News/NewsView.html?ID=259589&REFERER=NP
1092,2019-12-03,SK바이오팜美FDA서뇌전증신약후보물질임상1상승인받아,http://news.mk.co.kr/newsRead.php?year=2019&no=1008113
1093,2019-12-03,SK바이오팜신규뇌전증치료제미FDA임상1상IND승인,http://www.fnnews.com/news/201912030954400737
1094,2019-12-03,SK바이오팜신규뇌전증치료제연구착수美FDA임상1상승인,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019120309501375381
1095,2019-12-03,SK바이오팜새로운뇌전증치료제미국임상1상착수,http://www.etoday.co.kr/news/section/newsview.php?idxno=1829477
1096,2019-12-03,최태원의야심작SK바이오팜뇌전증신약후보물질FDA승인,http://www.ebn.co.kr/news/view/1011796/?sc=naver
1097,2019-12-03,SK바이오팜신규뇌전증치료제美FDA임상1상계획승인,http://biz.newdaily.co.kr/site/data/html/2019/12/03/2019120300044.html
1098,2019-12-03,SK바이오팜美FDA서뇌전증신약후보물질IND승인,http://www.sisafocus.co.kr/news/articleView.html?idxno=226975
1099,2019-12-03,SK바이오팜엑스코프리이어뇌전증신약개발착수,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912030097&t=NN
1100,2019-12-03,SK바이오팜뇌전증신약후보물질FDA임상1상승인,https://view.asiae.co.kr/article/2019120310085307682
1101,2019-12-03,특징주SK케미칼SK바이오팜뇌전증신약물질SKL24741美FDA임상1상승인↑,http://www.etoday.co.kr/news/section/newsview.php?idxno=1829495
1102,2019-12-03,SK바이오팜신규뇌전증치료제美1상승인,http://www.biospectator.com/view/news_view.php?varAtcId=9030
1103,2019-12-03,SK바이오팜신규뇌전증치료제연구개발본격착수,http://news.einfomax.co.kr/news/articleView.html?idxno=4059621
1104,2019-12-03,SK바이오팜신규뇌전증치료제연구개발본격착수,http://www.newsis.com/view/?id=NISX20191203_0000848517&cID=13001&pID=13000
1105,2019-12-03,SK바이오팜신규뇌전증치료제연구개발착수,http://yna.kr/AKR20191203054600017?did=1195m
1106,2019-12-03,SK바이오팜뇌전증신약후보美1상승인,http://news.mt.co.kr/mtview.php?no=2019120310000653083
1107,2019-12-03,SK바이오팜신규뇌전증치료제연구개발본격착수,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238133
1108,2019-12-03,SK바이오팜신규뇌전증치료제개발착수,https://www.hankyung.com/it/article/201912038804i
1109,2019-12-03,SK바이오팜제2엑스코프리개발본격화새약美임상허가,http://news.heraldcorp.com/view.php?ud=20191203000222
1110,2019-12-03,SK바이오팜뇌전증신약후보물질SKL24741연구개발본격화,https://asiatime.co.kr/news/newsview.php?ncode=1065575265413516
1111,2019-12-03,SK바이오팜엑스코프리이어뇌전증신약개발본격착수,http://www.whitepaper.co.kr/news/articleView.html?idxno=183616
1112,2019-12-03,SK바이오팜신규뇌전증치료제연구개발본격착수,http://www.metroseoul.co.kr/news/newsview?newscd=2019120300036
1113,2019-12-03,SK바이오팜신규뇌전증치료제개발본격착수,https://biz.chosun.com/site/data/html_dir/2019/12/03/2019120301176.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1114,2019-12-03,SK바이오팜뇌전증신약개발착수美FDA임상1상시험계획승인,http://www.newspim.com/news/view/20191203000282
1115,2019-12-03,SK바이오팜제2엑스코프리만든다,http://www.edaily.co.kr/news/newspath.asp?newsid=02246806622714912
1116,2019-12-03,SK바이오팜신규뇌전증치료제연구개발본격착수,http://www.newspost.kr/news/articleView.html?idxno=74190
1117,2019-12-03,SK바이오팜뇌전증후보물질임상1상계획FDA승인,http://health.chosun.com/site/data/html_dir/2019/12/03/2019120301243.html
1118,2019-12-03,SK바이오팜신규뇌전증치료제연구개발본격착수,http://www.bosa.co.kr/news/articleView.html?idxno=2117199
1119,2019-12-03,SK바이오팜신규뇌전증파이프라인미국1상승인”,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=004&oid=050&aid=0000052131
1120,2019-12-03,SK바이오팜뇌전증신약후보임상1상승인,http://www.beyondpost.co.kr/view.php?ud=201912031111431213c5c1bde209_30
1121,2019-12-03,SK바이오팜또다른뇌전증신약후보물질美FDA임상계획승인,http://news.mk.co.kr/newsRead.php?year=2019&no=1008753
1122,2019-12-03,SK바이오팜뇌전증신약美임상1상승인,http://www.dailymedi.com/detail.php?number=850312&thread=22r05
1123,2019-12-03,SK바이오팜신규뇌전증치료제美FDA임상1상계획승인,http://daily.hankooki.com/lpage/ittech/201912/dh20191203112636145630.htm
1124,2019-12-03,SK바이오팜새뇌전증치료제개발착수,http://www.techholic.co.kr/news/articleView.html?idxno=187696
1125,2019-12-03,SK바이오팜엑스코프리이어신규뇌전증치료제개발착수,http://www.econovill.com/news/articleView.html?idxno=379096
1126,2019-12-03,SK바이오팜두번째뇌전증치료제본격개발,http://www.medical-tribune.co.kr/news/articleView.html?idxno=89276
1127,2019-12-03,SK바이오팜신규뇌전증치료제연구개발본격착수,http://www.ajunews.com/view/20191203134232881
1128,2019-12-03,SK바이오팜신규뇌전증치료제연구개발본격착수,http://www.mdtoday.co.kr/mdtoday/index.html?no=371695
1129,2019-12-03,이데일리NSK바이오팜신규뇌전증치료제연구개발착수外,http://www.edaily.co.kr/news/newspath.asp?newsid=02879846622714912
1130,2019-12-03,SK바이오팜새뇌전증치료제개발 ,http://www.seoulfn.com/news/articleView.html?idxno=364457
1131,2019-12-03,SK바이오팜뇌전증신약후보물질임상FDA승인,http://www.shinailbo.co.kr/news/articleView.html?idxno=1229709
1132,2019-12-03,SK바이오팜또다른신규뇌전증치료제연구개발착수,http://www.thevaluenews.co.kr/news/view.php?idx=157606
1133,2019-12-03,SK바이오팜신규뇌전증치료제美FDA로부터1상승인획득,http://www.ekn.kr/news/article.html?no=467574
1134,2019-12-03,SK바이오팜신규뇌전증치료제연구개발본격화,http://inthenews.co.kr/article-26715/
1135,2019-12-03,SK바이오팜신규뇌전증치료제SKL24741美FDA1상계획승인,http://www.sporbiz.co.kr/news/articleView.html?idxno=397401
1136,2019-12-03,SK바이오팜세노바메이트이은신규뇌전증치료제연구속도,http://www.news2day.co.kr/143440
1137,2019-12-03,SK바이오팜신규뇌전증치료제임상본격화,http://www.finomy.com/news/articleView.html?idxno=72536
1138,2019-12-03,SK바이오팜뇌전증치료제판매허가이어새후보물질임상들어가,http://www.businesspost.co.kr/BP?command=article_view&num=153712
1139,2019-12-03,SK바이오팜두번째뇌전증신약개발시동,https://www.hankyung.com/it/article/2019120301861
1140,2019-12-03,SK바이오팜신규뇌전증치료제연구개발착수,http://www.dt.co.kr/contents.html?article_no=2019120402101431102001&ref=naver
1141,2019-12-04,출근길SK바이오팜제2엑스코프리개발본격화미국임상허가,http://moneys.mt.co.kr/news/mwView.php?no=2019120317248094085
1142,2019-12-04,SK바이오팜이뇌전증신약개발에또도전하는이유,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1074847
1143,2019-12-04,SK바이오팜신규뇌전증치료제개발착수,http://www.monews.co.kr/news/articleView.html?idxno=206860
1144,2019-12-04,SK바이오팜뇌전증신약후보물질美FDA임상1상계획승인,http://www.kukinews.com/news/article.html?no=724908
1145,2019-12-04,SK바이오팜뇌전증치료제SKL24741미1상승인받아,https://www.kpanews.co.kr/article/show.asp?idx=209201&category=D
1146,2019-12-04,SK바이오팜셀트리온훈풍제약바이오주반등조짐,http://www.upinews.kr/newsView/upi201912040084
1147,2019-12-04,SK바이오팜등兆단위대어대기내년IPO시장활황,http://www.sisajournal-e.com/news/articleView.html?idxno=210095
1148,2019-12-04,SK바이오팜카카오페이꿰찬NH투자내년IPO선두굳힌다,http://www.dt.co.kr/contents.html?article_no=2019120502101132049001&ref=naver
1149,2019-12-05,대기업바이오시계가빨라진다NEXTSK바이오팜은,http://www.viva100.com/main/view.php?key=20191205010001626
1150,2019-12-05,SK그룹임원인사뇌전증신약주도하는SK바이오팜조정우사장등,http://www.news2day.co.kr/143631
1151,2019-12-05,인사SK바이오팜조정우사장등총4명승진,http://www.econovill.com/news/articleView.html?idxno=379362
1152,2019-12-06,SK바이오팜FDA판매허가와우리의미래,https://www.kpanews.co.kr/column/show_youth.asp?idx=600&category=A
1153,2019-12-07,SK바이오팜성공으로뜨는범부처사업단2011년설립후기술이전만7조달해”,https://www.sedaily.com/NewsView/1VRZCJPCZE
1154,2019-12-09,신약개발새역사쓴SK바이오팜20년뚝심엑스코프리뇌전증신약美FDA넘었다,http://news.mk.co.kr/v2/economy/view.php?year=2019&no=1026625
1155,2019-12-11,SK바이오팜美뇌전증학회서세노바메이트연구결과발표,http://www.viva100.com/main/view.php?key=20191211010003753
1156,2019-12-11,SK바이오팜미국뇌전증학회연례회의AES참가,http://www.etnews.com/20191211000037
1157,2019-12-11,SK바이오팜미국뇌전증학회서세노바메이트연구발표,http://www.ebn.co.kr/news/view/1013010/?sc=naver
1158,2019-12-11,SK바이오팜미국뇌전증학회서엑스코프리연구결과발표,http://www.newspim.com/news/view/20191211000266
1159,2019-12-11,SK바이오팜美뇌전증학회서세노바메이트포스터발표,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912110165&t=NN
1160,2019-12-11,SK바이오팜미국서세노바메이트임상약동학결과발표,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238469
1161,2019-12-11,SK바이오팜뇌전증학회서세노바메이트연구결과결과발표,http://medipana.com/news/news_viewer.asp?NewsNum=250068&MainKind=A&NewsKind=5&vCount=12&vKind=1
1162,2019-12-11,SK바이오팜미국뇌전증학회연례회의참가,http://www.newsway.co.kr/news/view?tp=1&ud=2019121110143486327
1163,2019-12-11,SK바이오팜미국뇌전증학회연례회의참가,http://www.metroseoul.co.kr/news/newsview?newscd=2019121100046
1164,2019-12-11,SK바이오팜美뇌전증학회연례회의참가해세노바메이트연구결과발표,http://news.mk.co.kr/newsRead.php?year=2019&no=1035827
1165,2019-12-11,SK바이오팜美뇌전증학회서세노바메이트포스터발표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1832894
1166,2019-12-11,SK바이오팜美뇌전증학회서세노바에이트연구결과발표,http://biz.newdaily.co.kr/site/data/html/2019/12/11/2019121100061.html
1167,2019-12-11,SK바이오팜美뇌전증학회참가세노바메이트포스터발표,http://www.econovill.com/news/articleView.html?idxno=379807
1168,2019-12-11,SK바이오팜미국서세노바메이트추가정보발표,http://moneys.mt.co.kr/news/mwView.php?no=2019121111578089644
1169,2019-12-11,SK바이오팜美AES참가세노바메이트임상등발표,http://inthenews.co.kr/article-27749/
1170,2019-12-11,SK바이오팜美AES연례회의참가,https://asiatime.co.kr/news/newsview.php?ncode=1065589994623887
1171,2019-12-11,SK바이오팜미국뇌전증학회연례회의참가,http://www.fnnews.com/news/201912111702245293
1172,2019-12-11,SK바이오팜미국뇌전증학회연례회의참가,https://biz.chosun.com/site/data/html_dir/2019/12/11/2019121102541.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1173,2019-12-11,SK바이오팜미국뇌전증학회에서뇌전증치료제연구결과발표,http://www.businesspost.co.kr/BP?command=article_view&num=154845
1174,2019-12-11,SK바이오팜미국뇌전증학회연례회의참가,https://www.kpanews.co.kr/article/show.asp?idx=209394&category=D
1175,2019-12-11,SK바이오팜미국뇌전증학회참석성인부분발작세노바메이트정보공유,http://www.news2day.co.kr/144081
1176,2019-12-12,SK바이오팜미국뇌전증학회연례회의참가,http://www.ekn.kr/news/article.html?no=469447
1177,2019-12-13,최태원회장의바이오사랑SK바이오팜송년회깜짝등장,https://www.hankyung.com/economy/article/201912134126i
1178,2019-12-16,SK주가상승예상SK바이오팜상장뒤기업가치급등가능성,http://www.businesspost.co.kr/BP?command=article_view&num=155338
1179,2019-12-16,2020증시달구는바이오株IPOSK바이오팜CJ헬스케어大魚노려라,http://news.mk.co.kr/v2/economy/view.php?year=2019&no=1051534
1180,2019-12-23,마켓인사이트SK바이오팜카뱅내년IPO兆단위대어납시오,https://www.hankyung.com/finance/article/2019122370461
1181,2019-12-23,뇌전증치료제시장급성장SK바이오팜내년세계최대시장美공략,http://www.dt.co.kr/contents.html?article_no=2019122402101931102001&ref=naver
1182,2019-12-25,조정우SK바이오팜뇌전증신약으로미국에서매출1조에도전,http://www.businesspost.co.kr/BP?command=article_view&num=156772
1183,2019-12-26,SK바이오팜2020년상반기상장예상,http://www.nspna.com/news/?mode=view&newsid=401861
1184,2019-12-26,SK바이오팜상장하면오스코텍앱클론올릭스도기업가치재평가된다,http://www.businesspost.co.kr/BP?command=article_view&num=156829
1185,2019-12-26,신약개발업체SK바이오팜중소형바이오주에훈풍,http://www.choicenews.co.kr/news/articleView.html?idxno=66911
1186,2019-12-29,2020증시SK바이오팜카카오뱅크IPO시장대어가달군다,http://news1.kr/articles/?3803607
1187,2019-12-29,2020년IPOSK바이오팜등대어줄줄이대기주목,http://www.econovill.com/news/articleView.html?idxno=381232
1188,2019-12-29,SK바이오팜CJ헬스케어등2020년IPO달군다,http://www.ajunews.com/view/20191228124412256
1189,2019-12-30,기업S토커SK그룹지배구조개편핵심키SK바이오팜,https://www.ajunews.com/view/20191230072421789
1190,2019-12-30,코오롱신라젠에울고SK바이오팜에웃고,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912300325&t=NNv
1191,2019-12-30,거래소SK바이오팜코스피상장예심승인,http://www.newspim.com/news/view/20191230001218
1192,2019-12-30,SK바이오팜유가증권시장상장예비심사승인,http://www.fnnews.com/news/201912301810357497
1193,2019-12-30,마켓인SK바이오팜유가증권시장상장예비심사승인,http://www.edaily.co.kr/news/newspath.asp?newsid=03903206622723768
1194,2019-12-30,IPO대어SK바이오팜유가증권시장상장예비심사통과,http://news1.kr/articles/?3805193
1195,2019-12-30,토종신약쾌거SK바이오팜코스피상장예비심사통과,http://yna.kr/AKR20191230158100008?did=1195m
1196,2019-12-30,SK바이오팜유가증권시장상장예비심사통과,http://moneys.mt.co.kr/news/mwView.php?no=2019123018378053361
1197,2019-12-30,SK바이오팜코스피상장예비심사통과,https://cnbc.sbs.co.kr/article_hub/10000967625?division=NAVER
1198,2019-12-30,SK바이오팜코스피상장예비심사통과,http://www.etnews.com/20191230000367
1199,2019-12-30,시그널IPO대어SK바이오팜상장예비심사통과,https://signal.sedaily.com/NewsView/1VS9YE3141
1200,2019-12-30,SK바이오팜코스피상장예비심사통과,https://view.asiae.co.kr/article/2019123019255406915
1201,2019-12-30,SK바이오팜코스피상장발판마련거래소심사에서요건충족,http://www.businesspost.co.kr/BP?command=article_view&num=157455
1202,2019-12-30,거래소SK바이오팜상장예비심사승인,http://www.newsprime.co.kr/news/article.html?no=488659
1203,2019-12-30,거래소SK바이오팜코스피상장예비심사통과,http://www.etoday.co.kr/news/section/newsview.php?idxno=1839792
1204,2019-12-30,토종신약개발SK바이오팜코스피상장예비심사통과,http://news.mk.co.kr/newsRead.php?no=1098339&year=2019
1205,2019-12-30,시그널IPO대어SK바이오팜상장예비심사통과,https://www.sedaily.com/NewsView/1VS9YIF50R
1206,2019-12-31,내년강세장전망에매머드급IPO빅매치예고SK바이오팜포문열어,http://www.greened.kr/news/articleView.html?idxno=230472
1207,2019-12-31,IPO대어SK바이오팜코스피상장예비심사통과,http://www.whitepaper.co.kr/news/articleView.html?idxno=186708
1208,2019-12-31,마켓인사이트SK바이오팜내년상반기IPO대어출격예약,https://www.hankyung.com/finance/article/201912313218r
1209,2019-12-31,SK바이오팜코스피상장예비심사통과,http://www.newsway.co.kr/news/view?tp=1&ud=2019123109511187417
1210,2019-12-31,SK바이오팜태광실업CJ헬스케어兆단위몸값대어들IPO문똑똑,http://news.heraldcorp.com/view.php?ud=20191231000306
1211,2019-12-31,제약바이오업계결산코오롱생명과학부터SK바이오팜까지,http://www.news2day.co.kr/145502
1212,2019-12-31,SK바이오팜상장예비심사통과2020년IPO최대어주목,http://www.economytalk.kr/news/articleView.html?idxno=202658
